How tumours escape mass destruction
It is now well established that the immune system can control neoplastic development and growth in a process termed immunosurveillance. A link between host immunosurveillance and neoplastic progression is revealed in cases where the immune response becomes compromised due to genetic or other patholo...
Saved in:
| Published in | Oncogene Vol. 27; no. 45; pp. 5894 - 5903 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
06.10.2008
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | It is now well established that the immune system can control neoplastic development and growth in a process termed immunosurveillance. A link between host immunosurveillance and neoplastic progression is revealed in cases where the immune response becomes compromised due to genetic or other pathological conditions, resulting in a substantially increased incidence and rate of spontaneous tumour formation in both preclinical animal models and patients. It has also been demonstrated in tumour-bearing hosts that the tumorigenic process itself can promote a state of immunosuppression that, in turn, facilitates neoplastic progression. The ability of neoplastic populations to induce a hostile microenvironment through both cell contact-dependent and -independent immunosuppressive networks is a significant barrier to effective cell-mediated immunity and immunotherapy. Thus, a competent immune system is integral for the control of neoplastic disease, and dissecting the plethora of tumour escape mechanisms that disrupt this essential host defense capability is integral for the development of effective immunotherapeutic paradigms. |
|---|---|
| AbstractList | It is now well established that the immune system can control neoplastic development and growth in a process termed immunosurveillance. A link between host immunosurveillance and neoplastic progression is revealed in cases where the immune response becomes compromised due to genetic or other pathological conditions, resulting in a substantially increased incidence and rate of spontaneous tumour formation in both preclinical animal models and patients. It has also been demonstrated in tumour-bearing hosts that the tumorigenic process itself can promote a state of immunosuppression that, in turn, facilitates neoplastic progression. The ability of neoplastic populations to induce a hostile microenvironment through both cell contact-dependent and -independent immunosuppressive networks is a significant barrier to effective cell-mediated immunity and immunotherapy. Thus, a competent immune system is integral for the control of neoplastic disease, and dissecting the plethora of tumour escape mechanisms that disrupt this essential host defense capability is integral for the development of effective immunotherapeutic paradigms. It is now well established that the immune system can control neoplastic development and growth in a process termed immunosurveillance. A link between host immunosurveillance and neoplastic progression is revealed in cases where the immune response becomes compromised due to genetic or other pathological conditions, resulting in a substantially increased incidence and rate of spontaneous tumour formation in both preclinical animal models and patients. It has also been demonstrated in tumour-bearing hosts that the tumorigenic process itself can promote a state of immunosuppression that, in turn, facilitates neoplastic progression. The ability of neoplastic populations to induce a hostile microenvironment through both cell contact-dependent and -independent immunosuppressive networks is a significant barrier to effective cell-mediated immunity and immunotherapy. Thus, a competent immune system is integral for the control of neoplastic disease, and dissecting the plethora of tumour escape mechanisms that disrupt this essential host defense capability is integral for the development of effective immunotherapeutic paradigms.Oncogene (2008) 27, 5894-5903; doi:10.1038/onc.2008.268 It is now well established that the immune system can control neoplastic development and growth in a process termed immunosurveillance. A link between host immunosurveillance and neoplastic progression is revealed in cases where the immune response becomes compromised due to genetic or other pathological conditions, resulting in a substantially increased incidence and rate of spontaneous tumour formation in both preclinical animal models and patients. It has also been demonstrated in tumour-bearing hosts that the tumorigenic process itself can promote a state of immunosuppression that, in turn, facilitates neoplastic progression. The ability of neoplastic populations to induce a hostile microenvironment through both cell contact-dependent and -independent immunosuppressive networks is a significant barrier to effective cell-mediated immunity and immunotherapy. Thus, a competent immune system is integral for the control of neoplastic disease, and dissecting the plethora of tumour escape mechanisms that disrupt this essential host defense capability is integral for the development of effective immunotherapeutic paradigms. [PUBLICATION ABSTRACT] |
| Audience | Academic |
| Author | Abrams, S I Stewart, T J |
| Author_xml | – sequence: 1 givenname: T J surname: Stewart fullname: Stewart, T J organization: Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 2Current address: Cancer Immunology Research Program, The Peter MacCallum Cancer Institute, Level 2, Smorgon Family Building, St Andrews Place, East Melbourne, Victoria 3002, Australia – sequence: 2 givenname: S I surname: Abrams fullname: Abrams, S I email: scott.abrams@roswellpark.org organization: Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 3Current address: Department of Immunology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18836470$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkstrGzEQh0VxqJ20t57DUkNOWVfvxzGEpAkEcmnPQtbOhjVeyZF2Kf3vq8UmpqUm0kEw-uY3z3M0CzEAQl8IXhHM9LcY_IpirFdU6g9oQbiStRCGz9ACG4FrQxmdo_OcNxhjZTD9iOZEaya5wgu0fIi_qmHs45hyBdm7HVS9y7lqIA9p9EMXwyd01rpths-H9wL9vL_7cftQPz1_f7y9eaq9YHKoHajGKKeBeaIcUWtPmGCtoHQtJZeKKEPXzAFujQaNtWidN01jRDnQOMMu0NVed5fi61ji277LHrZbFyCO2UojqaIl9fdAShjHnNN3QWIU19pMist_wE3pSCjVWio5YVoKNcl9PUlRxYRhih-lXtwWbBfaOCTnp7j2hpT2a8mMLNTqP1S5DfSdLxNuu2L_y-F67-BTzDlBa3ep6136bQm20yLYsgh2WoSS8VTQ5SHVcd1Dc4QPky9AvQdy-QovkI61nBCs9nxww5jgTbBAEzMhfwCKy8Ti |
| CODEN | ONCNES |
| CitedBy_id | crossref_primary_10_1016_j_bulcan_2014_12_002 crossref_primary_10_1038_icb_2017_39 crossref_primary_10_1186_s12885_024_11933_3 crossref_primary_10_2217_imt_11_109 crossref_primary_10_1007_s11538_018_0412_8 crossref_primary_10_1371_journal_pone_0022763 crossref_primary_10_3389_fimmu_2018_00414 crossref_primary_10_1016_j_jconrel_2019_08_027 crossref_primary_10_1159_000480634 crossref_primary_10_1038_onc_2011_576 crossref_primary_10_1016_j_lungcan_2015_05_007 crossref_primary_10_1007_s10555_011_9280_5 crossref_primary_10_1016_j_bbmt_2010_09_019 crossref_primary_10_1634_theoncologist_2016_0046 crossref_primary_10_1089_thy_2015_0289 crossref_primary_10_1016_j_biomaterials_2013_03_029 crossref_primary_10_1177_1534735419890020 crossref_primary_10_1038_mt_2010_98 crossref_primary_10_1186_s13045_016_0277_y crossref_primary_10_1016_j_humimm_2016_06_011 crossref_primary_10_18632_oncotarget_4905 crossref_primary_10_1186_1745_6150_7_31 crossref_primary_10_1080_14756366_2020_1734800 crossref_primary_10_1093_gastro_goz061 crossref_primary_10_18632_oncotarget_26529 crossref_primary_10_1007_s10955_017_1945_1 crossref_primary_10_3389_fimmu_2019_01790 crossref_primary_10_2217_imt_11_111 crossref_primary_10_2217_imt_11_112 crossref_primary_10_3892_etm_2018_6425 crossref_primary_10_2217_imt_11_115 crossref_primary_10_1098_rsfs_2013_0010 crossref_primary_10_1093_glycob_cwt059 crossref_primary_10_1007_s00262_010_0873_6 crossref_primary_10_1002_rmv_694 crossref_primary_10_1016_j_canep_2010_10_004 crossref_primary_10_1038_s41416_019_0398_5 crossref_primary_10_1056_NEJMe0903177 crossref_primary_10_3389_fimmu_2018_01051 crossref_primary_10_1111_resp_14437 crossref_primary_10_1080_2162402X_2017_1342909 crossref_primary_10_1016_j_canlet_2017_12_032 crossref_primary_10_1016_j_ejca_2018_11_002 crossref_primary_10_1016_j_semcancer_2021_04_018 crossref_primary_10_1038_onc_2010_622 crossref_primary_10_1002_cam4_688 crossref_primary_10_1089_thy_2014_0134 crossref_primary_10_1158_1940_6207_CAPR_10_0043 crossref_primary_10_1007_s00262_013_1507_6 crossref_primary_10_1186_s13148_017_0358_y crossref_primary_10_1109_TPS_2010_2041075 crossref_primary_10_18632_oncotarget_4526 crossref_primary_10_1016_j_jtbi_2016_06_012 crossref_primary_10_1038_nrurol_2016_239 crossref_primary_10_1186_bcr3115 crossref_primary_10_1182_blood_2010_04_279893 crossref_primary_10_1007_s10654_018_0477_6 crossref_primary_10_1007_s11684_018_0674_4 crossref_primary_10_4155_tde_10_108 crossref_primary_10_1093_hmg_ddr102 crossref_primary_10_2217_fon_09_46 crossref_primary_10_1111_apm_12881 crossref_primary_10_1586_era_09_88 crossref_primary_10_1080_21505594_2015_1076614 crossref_primary_10_1038_bjc_2011_189 crossref_primary_10_3389_fonc_2020_604906 crossref_primary_10_1134_S0026893319050042 crossref_primary_10_1158_0008_5472_CAN_09_2472 crossref_primary_10_4161_2162402X_2014_984539 crossref_primary_10_18632_oncotarget_3066 crossref_primary_10_1016_S1995_7645_10_60074_0 crossref_primary_10_1097_CJI_0000000000000467 crossref_primary_10_3390_clinpract11030070 crossref_primary_10_1093_ndt_gfr264 crossref_primary_10_3390_pharmaceutics12080758 crossref_primary_10_1038_s41421_020_0145_3 crossref_primary_10_1007_s12253_009_9230_5 crossref_primary_10_1038_mt_2012_128 crossref_primary_10_1146_annurev_immunol_101320_125133 crossref_primary_10_1016_j_copbio_2013_09_005 crossref_primary_10_1371_journal_pone_0015194 crossref_primary_10_1158_0008_5472_CAN_12_0210 crossref_primary_10_2217_imt_12_107 crossref_primary_10_3892_ol_2016_5273 crossref_primary_10_1016_S1470_2045_17_30520_X crossref_primary_10_1016_j_ymeth_2016_08_011 crossref_primary_10_1155_2010_169484 crossref_primary_10_1186_1471_2407_14_24 crossref_primary_10_1038_nm0509_496 crossref_primary_10_1200_PO_16_00049 crossref_primary_10_1186_s12935_018_0536_9 crossref_primary_10_1007_s10585_016_9814_x crossref_primary_10_1016_j_apsb_2023_08_034 crossref_primary_10_1103_PhysRevE_84_031910 crossref_primary_10_1210_clinem_dgaa656 crossref_primary_10_1016_j_coph_2013_04_003 crossref_primary_10_4049_jimmunol_2200244 crossref_primary_10_1038_mt_2011_152 crossref_primary_10_1158_1535_7163_MCT_10_0590 crossref_primary_10_4049_jimmunol_1203373 crossref_primary_10_1016_j_suronc_2016_05_021 crossref_primary_10_1371_journal_pone_0296989 crossref_primary_10_3390_cells11111779 crossref_primary_10_4049_jimmunol_1201449 crossref_primary_10_4103_jcrt_JCRT_263_16 crossref_primary_10_4049_jimmunol_1000901 crossref_primary_10_1002_cam4_2120 crossref_primary_10_2147_IJN_S333197 crossref_primary_10_1155_2012_818214 crossref_primary_10_1016_j_oraloncology_2011_05_015 crossref_primary_10_2217_imt_10_2 crossref_primary_10_1038_s41598_021_00626_7 crossref_primary_10_1158_1078_0432_CCR_14_0879 crossref_primary_10_1016_j_coi_2017_01_005 crossref_primary_10_1038_modpathol_2010_130 crossref_primary_10_1097_TP_0b013e31823ffd39 crossref_primary_10_3233_JND_170219 crossref_primary_10_1080_0284186X_2023_2226330 crossref_primary_10_1186_s12964_021_00705_2 crossref_primary_10_1093_jjco_hyw087 crossref_primary_10_1080_08923973_2023_2239489 crossref_primary_10_1111_cas_15020 crossref_primary_10_1007_s12026_009_8125_6 crossref_primary_10_1172_JCI96784 crossref_primary_10_1016_j_imbio_2011_12_006 crossref_primary_10_3892_ijo_2016_3803 |
| Cites_doi | 10.1038/nri1668 10.1126/science.1076514 10.1158/1078-0432.CCR-04-0054 10.1126/science.291.5502.319 10.1200/JCO.2006.08.5829 10.1084/jem.192.5.755 10.4049/jimmunol.171.8.4164 10.1146/annurev.immunol.24.021605.090737 10.1158/0008-5472.CAN-06-4068 10.1080/00313020400011268 10.1038/nm976 10.4049/jimmunol.176.6.3374 10.1158/1078-0432.CCR-04-1469 10.1038/nri1415 10.1084/jem.190.3.355 10.1158/1078-0432.CCR-05-0883 10.1023/B:BREA.0000041579.51902.89 10.1097/01.mph.0000188112.42576.df 10.1007/s00262-005-0048-z 10.1158/1078-0432.CCR-06-0112 10.1038/82771 10.4049/jimmunol.170.12.6329 10.1038/83416 10.1073/pnas.0600937103 10.1084/jem.20050930 10.4049/jimmunol.174.4.1830 10.1073/pnas.192461099 10.1158/0008-5472.CAN-05-4303 10.1038/nri1961 10.1158/0008-5472.CAN-07-1228 10.1158/0008-5472.CAN-06-4084 10.1158/0008-5472.1045.65.3 10.4049/jimmunol.163.9.4886 10.1046/j.1365-2567.2002.01471.x 10.1016/j.ccr.2005.10.012 10.4049/jimmunol.176.6.3402 10.1084/jem.20030590 10.1146/annurev.immunol.21.120601.141135 10.1016/S1074-7613(03)00152-3 10.1016/S0092-8674(00)81683-9 10.1172/JCI31202 10.1016/S0065-2776(06)90001-7 10.1158/0008-5472.CAN-06-4174 10.1158/1078-0432.CCR-05-2750 10.1016/S0065-2776(06)90008-X 10.1073/pnas.1533209100 10.1158/1078-0432.728.11.2 10.1016/j.imlet.2007.06.001 10.1038/85330 10.1002/eji.200526046 10.4049/jimmunol.169.5.2756 10.1016/S0065-230X(08)60744-7 10.1016/S1471-4906(02)02255-X 10.1158/0008-5472.CAN-04-0757 10.1084/jem.20011624 10.1158/0008-5472.CAN-04-3232 10.1016/S0092-8674(00)81348-3 10.1158/1078-0432.CCR-07-0016 10.1038/nrc1167 10.1038/9525 10.1016/j.semcancer.2005.07.008 10.1038/nm1325 10.1158/1078-0432.CCR-06-2197 10.1084/jem.192.7.1027 10.4049/jimmunol.166.1.678 10.1038/nm1087 10.1073/pnas.96.5.2233 10.1146/annurev.immunol.21.120601.141040 10.1158/0008-5472.1089.65.3 10.1007/s00262-006-0183-1 10.1158/1078-0432.CCR-07-0409 10.1017/S1462399407000233 10.1038/nri1995 10.1084/jem.20022227 10.1146/annurev.immunol.21.120601.141122 10.1038/nature03954 10.1016/S0041-1345(98)01987-3 10.1084/jem.20050715 10.1016/j.ccr.2004.08.031 10.1182/blood-2007-06-094615 10.1158/0008-5472.CAN-04-4505 10.1002/cncr.20270 10.1182/blood-2005-07-2737 10.1084/jem.20042167 10.1158/0008-5472.CAN-07-0912 10.1158/0008-5472.CAN-06-1690 10.1006/cimm.2001.1785 10.1126/science.1900952 10.1038/nrc1256 10.1007/978-0-387-72005-0_22 10.1007/s00262-006-0272-1 10.1097/CJI.0b013e31802e085a 10.1126/science.271.5256.1734 10.1146/annurev.immunol.18.1.423 10.1038/nm1093 10.1158/0008-5472.CAN-04-4269 10.1016/j.coi.2007.02.001 10.4049/jimmunol.170.12.5973 |
| ContentType | Journal Article |
| Copyright | Macmillan Publishers Limited 2008 COPYRIGHT 2008 Nature Publishing Group Copyright Nature Publishing Group Oct 6, 2008 Macmillan Publishers Limited 2008. |
| Copyright_xml | – notice: Macmillan Publishers Limited 2008 – notice: COPYRIGHT 2008 Nature Publishing Group – notice: Copyright Nature Publishing Group Oct 6, 2008 – notice: Macmillan Publishers Limited 2008. |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TM 7TO 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PQEST PQQKQ PQUKI PRINS Q9U RC3 7T5 7X8 |
| DOI | 10.1038/onc.2008.268 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database (Proquest) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database ProQuest research library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts Immunology Abstracts MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts Research Library Prep MEDLINE - Academic Genetics Abstracts Research Library Prep |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology |
| EISSN | 1476-5594 |
| EndPage | 5903 |
| ExternalDocumentID | 1570371161 A190286396 10_1038_onc_2008_268 18836470 onc2008268 |
| Genre | Journal Article Research Support, N.I.H., Intramural Review |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: Intramural NIH HHS |
| GroupedDBID | - -Q- 0R 123 29N 2WC 39C 3O- 3V. 4.4 53G 5RE 70F 7X7 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AADWK AAPBV AAWBL AAYJO AAZLF ABAWZ ABDBF ABDEU ABFLS ABGIJ ABPTK ABUWG ACGFS ACKTT ACPRK ADBBV ADHDB ADQMX AEDAW AEJRE AENEX AEXYK AFKRA AFSHS AGEZK AHMBA AHSBF AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AXYYD AZFZN AZQEC B0M BBAFP BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG COF CS3 DIK DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EPL ESX F5P FDQFY FEDTE FERAY FIZPM FRP FSGXE FYUFA GNUQQ GUQSH HCIFZ HVGLF HZ IAO IHR INH INR ITC JSO KQ8 L7B LK8 M0L M1P M2O M7P N9A NAO O9- OK1 OVD P2P PADUT PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q- Q2X RIG RNS RNT RNTTT SNX SNYQT SV3 SWTZT TAOOD TBHMF TDRGL TEORI TSG TUS W2D WH7 ZA5 --- 0R~ 36B 406 AANZL ABAKF ABJNI ABLJU ABZZP ACAOD ACGFO ACMJI ACRQY ACZOJ ADFRT AEMSY AEVLU AFBBN AGHAI AGQEE AILAN ALIPV AMYLF CCPQU DNIVK DPUIP EMOBN HMCUK HZ~ IWAJR JZLTJ NQJWS NXXTH SOHCF SRMVM UKHRP ~8M AAYZH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TM 7TO 7U9 7XB 8FD 8FK FR3 H94 K9. MBDVC P64 Q9U RC3 7T5 7X8 |
| ID | FETCH-LOGICAL-c536t-ae7d97a8e3c17a17bc1353f522b664671792b3ae0f98e8085fac9dd95555eda93 |
| IEDL.DBID | 8C1 |
| ISSN | 0950-9232 |
| IngestDate | Fri Oct 25 23:47:26 EDT 2024 Fri Oct 25 03:59:35 EDT 2024 Fri Oct 25 09:33:51 EDT 2024 Thu Oct 10 19:58:01 EDT 2024 Tue Nov 19 05:16:19 EST 2024 Tue Nov 19 21:42:54 EST 2024 Tue Nov 12 23:43:59 EST 2024 Thu Nov 21 22:21:21 EST 2024 Tue Oct 15 23:36:03 EDT 2024 Fri Oct 11 20:47:27 EDT 2024 Thu Oct 07 19:37:28 EDT 2021 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 45 |
| Keywords | tumour escape immunosuppression tumour microenvironment tumour immunity immunosurveillance |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c536t-ae7d97a8e3c17a17bc1353f522b664671792b3ae0f98e8085fac9dd95555eda93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Feature-3 ObjectType-Review-2 |
| OpenAccessLink | http://dx.doi.org/10.1038/onc.2008.268 |
| PMID | 18836470 |
| PQID | 227359374 |
| PQPubID | 36330 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_69627288 proquest_miscellaneous_21340442 proquest_miscellaneous_19748898 proquest_journals_2641386572 proquest_journals_227359374 gale_infotracmisc_A190286396 gale_infotracacademiconefile_A190286396 crossref_primary_10_1038_onc_2008_268 pubmed_primary_18836470 springer_journals_10_1038_onc_2008_268 nature_primary_onc2008268 |
| ProviderPackageCode | ABDEU AEDAW AAZLF -Q- AADWK AAYJO 70F ADQMX EE. RNTTT SWTZT ABGIJ RNT NAO |
| PublicationCentury | 2000 |
| PublicationDate | 2008-10-06 |
| PublicationDateYYYYMMDD | 2008-10-06 |
| PublicationDate_xml | – month: 10 year: 2008 text: 2008-10-06 day: 06 |
| PublicationDecade | 2000 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England – name: New York |
| PublicationTitle | Oncogene |
| PublicationTitleAbbrev | Oncogene |
| PublicationTitleAlternate | Oncogene |
| PublicationYear | 2008 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Mirza, N, Fishman, M, Fricke, I, Dunn, M, Neuger, AM, Frost, TJ 2006; 66 Kortylewski, M, Kujawski, M, Wang, T, Wei, S, Zhang, S, Pilon-Thomas, S 2005; 11 Steinman, RM, Hawiger, D, Nussenzweig, MC 2003; 21 Wang, T, Niu, G, Kortylewski, M, Burdelya, L, Shain, K, Zhang, S 2004; 10 Leach, DR, Krummel, MF, Allison, JP 1996; 271 Ochoa, AC, Zea, AH, Hernandez, C, Rodriguez, PC 2007; 13 Li, MO, Wan, YY, Sanjabi, S, Robertson, AK, Flavell, RA 2006; 24 Gordon, N, Arndt, CA, Hawkins, DS, Doherty, DK, Inwards, CY, Munsell, MF 2005; 27 Almand, B, Clark, JI, Nikitina, E, van Beynen, J, English, NR, Knight, SC 2001; 166 Jung, YJ, Kim, JY, Park, JH 2004; 13 Penn, I 1999; 31 Freeman, GJ, Long, AJ, Iwai, Y, Bourque, K, Chernova, T, Nishimura, H 2000; 192 Shevach, EM 2000; 18 Flies, DB, Chen, L 2007; 30 Rodriguez, PC, Hernandez, CP, Quiceno, D, Dubinett, SM, Zabaleta, J, Ochoa, JB 2005; 202 Sinha, P, Clements, VK, Fulton, AM, Ostrand-Rosenberg, S 2007; 67 Hanahan, D, Weinberg, RA 2000; 100 Litzinger, MT, Fernando, R, Curiel, TJ, Grosenbach, DW, Schlom, J, Palena, C 2007; 110 Bui, JD, Schreiber, RD 2007; 19 Keane, MM, Ettenberg, SA, Lowrey, GA, Russell, EK, Lipkowitz, S 1996; 56 Terabe, M, Matsui, S, Park, JM, Mamura, M, Noben-Trauth, N, Donaldson, DD 2003; 198 Liu, K, Caldwell, SA, Abrams, SI 2005b; 65 Demaria, S, Kawashima, N, Yang, AM, Devitt, ML, Babb, JS, Allison, JP 2005; 11 Sadun, RE, Sachsman, SM, Chen, X, Christenson, KW, Morris, WZ, Hu, P 2007; 13 Yang, L, DeBusk, LM, Fukuda, K, Fingleton, B, Green-Jarvis, B, Shyr, Y 2004; 6 Curiel, TJ, Coukos, G, Zou, L, Alvarez, X, Cheng, P, Mottram, P 2004; 10 Krambeck, AE, Thompson, RH, Dong, H, Lohse, CM, Park, ES, Kuntz, SM 2006; 103 Sakaguchi, S 2004; 22 Liu, K, Abrams, SI 2003b; 170 Vogelstein, B, Kinzler, KW 2004; 10 Harizi, H, Juzan, M, Grosset, C, Rashedi, M, Gualde, N 2001; 209 Ochsenbein, AF, Klenerman, P, Karrer, U, Ludewig, B, Pericin, M, Hengartner, H 1999; 96 Pollard, JW 2004; 4 Liu, K, Caldwell, SA, Greeneltch, KM, Yang, D, Abrams, SI 2006; 176 Andreola, G, Rivoltini, L, Castelli, C, Huber, V, Perego, P, Deho, P 2002; 195 Smyth, MJ, Thia, KY, Street, SE, MacGregor, D, Godfrey, DI, Trapani, JA 2000; 192 Lee, PP, Yee, C, Savage, PA, Fong, L, Brockstedt, D, Weber, JS 1999; 5 Zhou, G, Drake, CG, Levitsky, HI 2006; 107 Nishimura, H, Okazaki, T, Tanaka, Y, Nakatani, K, Hara, M, Matsumori, A 2001; 291 Ohigashi, Y, Sho, M, Yamada, Y, Tsurui, Y, Hamada, K, Ikeda, N 2005; 11 Chang, CC, Ferrone, S 2007; 56 Giovarelli, M, Musiani, P, Garotta, G, Ebner, R, Di Carlo, E, Kim, Y 1999; 163 Fricke, I, Mirza, N, Dupont, J, Lockhart, C, Jackson, A, Lee, JH 2007; 13 Lin, EY, Pollard, JW 2007; 67 van Elsas, A, Hurwitz, AA, Allison, JP 1999; 190 Ferris, RL, Whiteside, TL, Ferrone, S 2006; 12 Bosque, A, Pardo, J, Martinez-Lorenzo, MJ, Lasierra, P, Larrad, L, Marzo, I 2005; 35 Ercolini, AM, Ladle, BH, Manning, EA, Pfannenstiel, LW, Armstrong, TD, Machiels, JP 2005; 201 Ichihara, F, Kono, K, Takahashi, A, Kawaida, H, Sugai, H, Fujii, H 2003; 9 Korman, AJ, Peggs, KS, Allison, JP 2006; 90 Latchman, Y, Wood, CR, Chernova, T, Chaudhary, D, Borde, M, Chernova, I 2001; 2 Espana, L, Fernandez, Y, Rubio, N, Torregrosa, A, Blanco, J, Sierra, A 2004; 87 Smyth, MJ, Dunn, GP, Schreiber, RD 2006; 90 Liu, K, Caldwell, SA, Abrams, SI 2005a; 65 Whiteside, TL 2006; 16 Gallimore, A, Sakaguchi, S 2002; 107 Dunn, GP, Koebel, CM, Schreiber, RD 2006; 6 Kusmartsev, S, Gabrilovich, DI 2006; 55 Schmielau, J, Finn, OJ 2001; 61 Liyanage, UK, Moore, TT, Joo, HG, Tanaka, Y, Herrmann, V, Doherty, G 2002; 169 Reckamp, KL, Krysan, K, Morrow, JD, Milne, GL, Newman, RA, Tucker, C 2006; 12 Takeda, K, Hayakawa, Y, Smyth, MJ, Kayagaki, N, Yamaguchi, N, Kakuta, S 2001; 7 Otten, GR, Germain, RN 1991; 251 Dudley, ME, Wunderlich, JR, Robbins, PF, Yang, JC, Hwu, P, Schwartzentruber, DJ 2002; 298 Abrams, SI 2004; 6 Stewart, TJ, Greeneltch, KM, Lutsiak, ME, Abrams, SI 2007; 9 Dudley, ME, Rosenberg, SA 2003; 3 Hoffmann, TK, Dworacki, G, Tsukihiro, T, Meidenbauer, N, Gooding, W, Johnson, JT 2002; 8 Krammer, PH, Galle, PR, Moller, P, Debatin, KM 1998; 75 Lopez-Albaitero, A, Nayak, JV, Ogino, T, Machandia, A, Gooding, W, DeLeo, AB 2006; 176 Holtschke, T, Lohler, J, Kanno, Y, Fehr, T, Giese, N, Rosenbauer, F 1996; 87 Kuss, I, Hathaway, B, Ferris, RL, Gooding, W, Whiteside, TL 2004; 10 Terabe, M, Matsui, S, Noben-Trauth, N, Chen, H, Watson, C, Donaldson, DD 2000; 1 Cuenca, A, Cheng, F, Wang, H, Brayer, J, Horna, P, Gu, L 2003; 63 Suzuki, E, Kapoor, V, Jassar, AS, Kaiser, LR, Albelda, SM 2005; 11 Thompson, RH, Kuntz, SM, Leibovich, BC, Dong, H, Lohse, CM, Webster, WS 2006; 66 Ormandy, LA, Hillemann, T, Wedemeyer, H, Manns, MP, Greten, TF, Korangy, F 2005; 65 Owen-Schaub, L, Chan, H, Cusack, JC, Roth, J, Hill, LL 2000; 17 Serafini, P, Carbley, R, Noonan, KA, Tan, G, Bronte, V, Borrello, I 2004; 64 Worth, LL, Lafleur, EA, Jia, SF, Kleinerman, ES 2002; 9 Liu, K, McDuffie, E, Abrams, SI 2003; 171 Overwijk, WW, Theoret, MR, Finkelstein, SE, Surman, DR, de Jong, LA, Vyth-Dreese, FA 2003; 198 Hirano, F, Kaneko, K, Tamura, H, Dong, H, Wang, S, Ichikawa, M 2005; 65 Blank, C, Mackensen, A 2007; 56 Yu, H, Kortylewski, M, Pardoll, D 2007; 7 Street, SE, Zerafa, N, Iezzi, M, Westwood, JA, Stagg, J, Musiani, P 2007; 67 Koneru, M, Schaer, D, Monu, N, Ayala, A, Frey, AB 2005; 174 Liu, K, Abrams, SI 2003a; 170 Thomas, DA, Massague, J 2005; 8 von Reyher, U, Strater, J, Kittstein, W, Gschwendt, M, Krammer, PH, Moller, P 1998; 58 Bronte, V, Zanovello, P 2005; 5 Phan, GQ, Yang, JC, Sherry, RM, Hwu, P, Topalian, SL, Schwartzentruber, DJ 2003; 100 Kim, R, Emi, M, Tanabe, K, Uchida, Y, Toge, T 2004; 100 Pawelec, G, Ouyang, Q, Colonna-Romano, G, Candore, G, Lio, D, Caruso, C 2002; 23 Woo, EY, Chu, CS, Goletz, TJ, Schlienger, K, Yeh, H, Coukos, G 2001; 61 Filipazzi, P, Valenti, R, Huber, V, Pilla, L, Canese, P, Iero, M 2007; 25 Sica, GL, Choi, IH, Zhu, G, Tamada, K, Wang, SD, Tamura, H 2003; 18 Nagaraj, S, Gabrilovich, DI 2007; 601 Iwai, Y, Ishida, M, Tanaka, Y, Okazaki, T, Honjo, T, Minato, N 2002; 99 Bron, LP, Scolyer, RA, Thompson, JF, Hersey, P 2004; 36 Pardoll, D 2003; 21 Yang, D, Thangaraju, M, Greeneltch, K, Browning, DD, Schoenlein, PV, Tamura, T 2007; 67 Greeneltch, K, Schneider, M, Steinberg, SM, Liewehr, DJ, Stewart, TJ, Liu, K 2007; 67 Curiel, TJ 2007; 117 Kryczek, I, Zou, L, Rodriguez, P, Zhu, G, Wei, S, Mottram, P 2006; 203 Zea, AH, Rodriguez, PC, Atkins, MB, Hernandez, C, Signoretti, S, Zabaleta, J 2005; 65 Willimsky, G, Blankenstein, T 2005; 437 Zamanakou, M, Germenis, AE, Karanikas, V 2007; 111 Vakkila, J, Lotze, MT 2004; 4 Koneru, Schaer, Monu, Ayala, Frey (CR38) 2005; 174 Serafini, Carbley, Noonan, Tan, Bronte, Borrello (CR80) 2004; 64 Willimsky, Blankenstein (CR101) 2005; 437 Overwijk, Theoret, Finkelstein, Surman, de Jong, Vyth-Dreese (CR68) 2003; 198 Woo, Chu, Goletz, Schlienger, Yeh, Coukos (CR102) 2001; 61 Dudley, Rosenberg (CR14) 2003; 3 Ercolini, Ladle, Manning, Pfannenstiel, Armstrong, Machiels (CR17) 2005; 201 Pardoll (CR70) 2003; 21 Shevach (CR81) 2000; 18 Smyth, Dunn, Schreiber (CR84) 2006; 90 Keane, Ettenberg, Lowrey, Russell, Lipkowitz (CR36) 1996; 56 Liu, Abrams (CR52) 2003; 170 Otten, Germain (CR67) 1991; 251 Kryczek, Zou, Rodriguez, Zhu, Wei, Mottram (CR43) 2006; 203 Blank, Mackensen (CR4) 2007; 56 Nishimura, Okazaki, Tanaka, Nakatani, Hara, Matsumori (CR62) 2001; 291 van Elsas, Hurwitz, Allison (CR96) 1999; 190 Street, Zerafa, Iezzi, Westwood, Stagg, Musiani (CR88) 2007; 67 Liu, Caldwell, Greeneltch, Yang, Abrams (CR56) 2006; 176 Sadun, Sachsman, Chen, Christenson, Morris, Hu (CR77) 2007; 13 Ormandy, Hillemann, Wedemeyer, Manns, Greten, Korangy (CR66) 2005; 65 Demaria, Kawashima, Yang, Devitt, Babb, Allison (CR13) 2005; 11 Dunn, Koebel, Schreiber (CR16) 2006; 6 Krambeck, Thompson, Dong, Lohse, Park, Kuntz (CR41) 2006; 103 Sica, Choi, Zhu, Tamada, Wang, Tamura (CR82) 2003; 18 Bron, Scolyer, Thompson, Hersey (CR6) 2004; 36 Freeman, Long, Iwai, Bourque, Chernova, Nishimura (CR22) 2000; 192 Latchman, Wood, Chernova, Chaudhary, Borde, Chernova (CR46) 2001; 2 Leach, Krummel, Allison (CR47) 1996; 271 Pawelec, Ouyang, Colonna-Romano, Candore, Lio, Caruso (CR71) 2002; 23 von Reyher, Strater, Kittstein, Gschwendt, Krammer, Moller (CR98) 1998; 58 Phan, Yang, Sherry, Hwu, Topalian, Schwartzentruber (CR73) 2003; 100 Schmielau, Finn (CR79) 2001; 61 Hirano, Kaneko, Tamura, Dong, Wang, Ichikawa (CR30) 2005; 65 Liu, Abrams (CR53) 2003; 170 Kusmartsev, Gabrilovich (CR44) 2006; 55 Vogelstein, Kinzler (CR97) 2004; 10 Liu, Caldwell, Abrams (CR55) 2005; 65 Curiel (CR11) 2007; 117 Gordon, Arndt, Hawkins, Doherty, Inwards, Munsell (CR26) 2005; 27 Flies, Chen (CR21) 2007; 30 Stewart, Greeneltch, Lutsiak, Abrams (CR87) 2007; 9 Kortylewski, Kujawski, Wang, Wei, Zhang, Pilon-Thomas (CR40) 2005; 11 Reckamp, Krysan, Morrow, Milne, Newman, Tucker (CR75) 2006; 12 Wang, Niu, Kortylewski, Burdelya, Shain, Zhang (CR99) 2004; 10 Terabe, Matsui, Noben-Trauth, Chen, Watson, Donaldson (CR91) 2000; 1 Chang, Ferrone (CR9) 2007; 56 Hoffmann, Dworacki, Tsukihiro, Meidenbauer, Gooding, Johnson (CR31) 2002; 8 Greeneltch, Schneider, Steinberg, Liewehr, Stewart, Liu (CR27) 2007; 67 Krammer, Galle, Moller, Debatin (CR42) 1998; 75 Penn (CR72) 1999; 31 Worth, Lafleur, Jia, Kleinerman (CR103) 2002; 9 Bosque, Pardo, Martinez-Lorenzo, Lasierra, Larrad, Marzo (CR5) 2005; 35 Litzinger, Fernando, Curiel, Grosenbach, Schlom, Palena (CR51) 2007; 110 Owen-Schaub, Chan, Cusack, Roth, Hill (CR69) 2000; 17 Holtschke, Lohler, Kanno, Fehr, Giese, Rosenbauer (CR32) 1996; 87 Terabe, Matsui, Park, Mamura, Noben-Trauth, Donaldson (CR92) 2003; 198 Suzuki, Kapoor, Jassar, Kaiser, Albelda (CR89) 2005; 11 Whiteside (CR100) 2006; 16 Ichihara, Kono, Takahashi, Kawaida, Sugai, Fujii (CR33) 2003; 9 Ohigashi, Sho, Yamada, Tsurui, Hamada, Ikeda (CR65) 2005; 11 Zamanakou, Germenis, Karanikas (CR107) 2007; 111 Dudley, Wunderlich, Robbins, Yang, Hwu, Schwartzentruber (CR15) 2002; 298 Espana, Fernandez, Rubio, Torregrosa, Blanco, Sierra (CR18) 2004; 87 Kim, Emi, Tanabe, Uchida, Toge (CR37) 2004; 100 Ferris, Whiteside, Ferrone (CR19) 2006; 12 Smyth, Thia, Street, MacGregor, Godfrey, Trapani (CR85) 2000; 192 Sinha, Clements, Fulton, Ostrand-Rosenberg (CR83) 2007; 67 Yang, Thangaraju, Greeneltch, Browning, Schoenlein, Tamura (CR104) 2007; 67 Li, Wan, Sanjabi, Robertson, Flavell (CR49) 2006; 24 Takeda, Hayakawa, Smyth, Kayagaki, Yamaguchi, Kakuta (CR90) 2001; 7 Jung, Kim, Park (CR35) 2004; 13 Abrams (CR1) 2004; 6 Nagaraj, Gabrilovich (CR61) 2007; 601 Zhou, Drake, Levitsky (CR109) 2006; 107 Liyanage, Moore, Joo, Tanaka, Herrmann, Doherty (CR58) 2002; 169 Bui, Schreiber (CR8) 2007; 19 Lee, Yee, Savage, Fong, Brockstedt, Weber (CR48) 1999; 5 Ochoa, Zea, Hernandez, Rodriguez (CR63) 2007; 13 Yu, Kortylewski, Pardoll (CR106) 2007; 7 Cuenca, Cheng, Wang, Brayer, Horna, Gu (CR10) 2003; 63 Korman, Peggs, Allison (CR39) 2006; 90 Gallimore, Sakaguchi (CR24) 2002; 107 Giovarelli, Musiani, Garotta, Ebner, Di Carlo, Kim (CR25) 1999; 163 Ochsenbein, Klenerman, Karrer, Ludewig, Pericin, Hengartner (CR64) 1999; 96 Filipazzi, Valenti, Huber, Pilla, Canese, Iero (CR20) 2007; 25 Lin, Pollard (CR50) 2007; 67 Steinman, Hawiger, Nussenzweig (CR86) 2003; 21 Hanahan, Weinberg (CR28) 2000; 100 Vakkila, Lotze (CR95) 2004; 4 Bronte, Zanovello (CR7) 2005; 5 Kuss, Hathaway, Ferris, Gooding, Whiteside (CR45) 2004; 10 Mirza, Fishman, Fricke, Dunn, Neuger, Frost (CR60) 2006; 66 Pollard (CR74) 2004; 4 Yang, DeBusk, Fukuda, Fingleton, Green-Jarvis, Shyr (CR105) 2004; 6 Thomas, Massague (CR93) 2005; 8 Fricke, Mirza, Dupont, Lockhart, Jackson, Lee (CR23) 2007; 13 Rodriguez, Hernandez, Quiceno, Dubinett, Zabaleta, Ochoa (CR76) 2005; 202 Liu, McDuffie, Abrams (CR57) 2003; 171 Zea, Rodriguez, Atkins, Hernandez, Signoretti, Zabaleta (CR108) 2005; 65 Almand, Clark, Nikitina, van Beynen, English, Knight (CR2) 2001; 166 Sakaguchi (CR78) 2004; 22 Lopez-Albaitero, Nayak, Ogino, Machandia, Gooding, DeLeo (CR59) 2006; 176 Liu, Caldwell, Abrams (CR54) 2005; 65 Curiel, Coukos, Zou, Alvarez, Cheng, Mottram (CR12) 2004; 10 Andreola, Rivoltini, Castelli, Huber, Perego, Deho (CR3) 2002; 195 Harizi, Juzan, Grosset, Rashedi, Gualde (CR29) 2001; 209 Iwai, Ishida, Tanaka, Okazaki, Honjo, Minato (CR34) 2002; 99 Thompson, Kuntz, Leibovich, Dong, Lohse, Webster (CR94) 2006; 66 MO Li (BFonc2008268_CR49) 2006; 24 MJ Smyth (BFonc2008268_CR85) 2000; 192 TJ Curiel (BFonc2008268_CR11) 2007; 117 S Nagaraj (BFonc2008268_CR61) 2007; 601 GQ Phan (BFonc2008268_CR73) 2003; 100 SE Street (BFonc2008268_CR88) 2007; 67 B Vogelstein (BFonc2008268_CR97) 2004; 10 LA Ormandy (BFonc2008268_CR66) 2005; 65 GL Sica (BFonc2008268_CR82) 2003; 18 MT Litzinger (BFonc2008268_CR51) 2007; 110 GP Dunn (BFonc2008268_CR16) 2006; 6 I Penn (BFonc2008268_CR72) 1999; 31 M Terabe (BFonc2008268_CR91) 2000; 1 GJ Freeman (BFonc2008268_CR22) 2000; 192 I Fricke (BFonc2008268_CR23) 2007; 13 K Greeneltch (BFonc2008268_CR27) 2007; 67 TL Whiteside (BFonc2008268_CR100) 2006; 16 AH Zea (BFonc2008268_CR108) 2005; 65 JW Pollard (BFonc2008268_CR74) 2004; 4 K Liu (BFonc2008268_CR57) 2003; 171 K Liu (BFonc2008268_CR55) 2005; 65 DR Leach (BFonc2008268_CR47) 1996; 271 K Liu (BFonc2008268_CR56) 2006; 176 N Gordon (BFonc2008268_CR26) 2005; 27 D Hanahan (BFonc2008268_CR28) 2000; 100 MJ Smyth (BFonc2008268_CR84) 2006; 90 DB Flies (BFonc2008268_CR21) 2007; 30 P Sinha (BFonc2008268_CR83) 2007; 67 JD Bui (BFonc2008268_CR8) 2007; 19 S Kusmartsev (BFonc2008268_CR44) 2006; 55 EY Woo (BFonc2008268_CR102) 2001; 61 I Kuss (BFonc2008268_CR45) 2004; 10 A Gallimore (BFonc2008268_CR24) 2002; 107 UK Liyanage (BFonc2008268_CR58) 2002; 169 AM Ercolini (BFonc2008268_CR17) 2005; 201 ME Dudley (BFonc2008268_CR15) 2002; 298 G Andreola (BFonc2008268_CR3) 2002; 195 A Cuenca (BFonc2008268_CR10) 2003; 63 V Bronte (BFonc2008268_CR7) 2005; 5 PH Krammer (BFonc2008268_CR42) 1998; 75 TJ Curiel (BFonc2008268_CR12) 2004; 10 GR Otten (BFonc2008268_CR67) 1991; 251 RM Steinman (BFonc2008268_CR86) 2003; 21 G Willimsky (BFonc2008268_CR101) 2005; 437 B Almand (BFonc2008268_CR2) 2001; 166 AF Ochsenbein (BFonc2008268_CR64) 1999; 96 TJ Stewart (BFonc2008268_CR87) 2007; 9 M Kortylewski (BFonc2008268_CR40) 2005; 11 EY Lin (BFonc2008268_CR50) 2007; 67 A Bosque (BFonc2008268_CR5) 2005; 35 DA Thomas (BFonc2008268_CR93) 2005; 8 LL Worth (BFonc2008268_CR103) 2002; 9 AC Ochoa (BFonc2008268_CR63) 2007; 13 TK Hoffmann (BFonc2008268_CR31) 2002; 8 M Terabe (BFonc2008268_CR92) 2003; 198 M Zamanakou (BFonc2008268_CR107) 2007; 111 A van Elsas (BFonc2008268_CR96) 1999; 190 C Blank (BFonc2008268_CR4) 2007; 56 S Demaria (BFonc2008268_CR13) 2005; 11 I Kryczek (BFonc2008268_CR43) 2006; 203 CC Chang (BFonc2008268_CR9) 2007; 56 SI Abrams (BFonc2008268_CR1) 2004; 6 H Yu (BFonc2008268_CR106) 2007; 7 RH Thompson (BFonc2008268_CR94) 2006; 66 L Yang (BFonc2008268_CR105) 2004; 6 LP Bron (BFonc2008268_CR6) 2004; 36 K Takeda (BFonc2008268_CR90) 2001; 7 A Lopez-Albaitero (BFonc2008268_CR59) 2006; 176 E Suzuki (BFonc2008268_CR89) 2005; 11 Y Ohigashi (BFonc2008268_CR65) 2005; 11 Y Latchman (BFonc2008268_CR46) 2001; 2 G Zhou (BFonc2008268_CR109) 2006; 107 D Yang (BFonc2008268_CR104) 2007; 67 M Koneru (BFonc2008268_CR38) 2005; 174 AE Krambeck (BFonc2008268_CR41) 2006; 103 J Schmielau (BFonc2008268_CR79) 2001; 61 F Hirano (BFonc2008268_CR30) 2005; 65 S Sakaguchi (BFonc2008268_CR78) 2004; 22 R Kim (BFonc2008268_CR37) 2004; 100 M Giovarelli (BFonc2008268_CR25) 1999; 163 P Serafini (BFonc2008268_CR80) 2004; 64 KL Reckamp (BFonc2008268_CR75) 2006; 12 ME Dudley (BFonc2008268_CR14) 2003; 3 WW Overwijk (BFonc2008268_CR68) 2003; 198 PP Lee (BFonc2008268_CR48) 1999; 5 J Vakkila (BFonc2008268_CR95) 2004; 4 L Espana (BFonc2008268_CR18) 2004; 87 T Holtschke (BFonc2008268_CR32) 1996; 87 RL Ferris (BFonc2008268_CR19) 2006; 12 N Mirza (BFonc2008268_CR60) 2006; 66 K Liu (BFonc2008268_CR54) 2005; 65 H Harizi (BFonc2008268_CR29) 2001; 209 MM Keane (BFonc2008268_CR36) 1996; 56 U von Reyher (BFonc2008268_CR98) 1998; 58 F Ichihara (BFonc2008268_CR33) 2003; 9 L Owen-Schaub (BFonc2008268_CR69) 2000; 17 YJ Jung (BFonc2008268_CR35) 2004; 13 G Pawelec (BFonc2008268_CR71) 2002; 23 T Wang (BFonc2008268_CR99) 2004; 10 D Pardoll (BFonc2008268_CR70) 2003; 21 Y Iwai (BFonc2008268_CR34) 2002; 99 EM Shevach (BFonc2008268_CR81) 2000; 18 K Liu (BFonc2008268_CR53) 2003; 170 PC Rodriguez (BFonc2008268_CR76) 2005; 202 AJ Korman (BFonc2008268_CR39) 2006; 90 RE Sadun (BFonc2008268_CR77) 2007; 13 K Liu (BFonc2008268_CR52) 2003; 170 H Nishimura (BFonc2008268_CR62) 2001; 291 P Filipazzi (BFonc2008268_CR20) 2007; 25 |
| References_xml | – volume: 96 start-page: 2233 year: 1999 end-page: 2238 article-title: Immune surveillance against a solid tumor fails because of immunological ignorance publication-title: Proc Natl Acad Sci USA contributor: fullname: Hengartner, H – volume: 192 start-page: 1027 year: 2000 end-page: 1034 article-title: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation publication-title: J Exp Med contributor: fullname: Nishimura, H – volume: 75 start-page: 251 year: 1998 end-page: 273 article-title: CD95(APO-1 Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells publication-title: Adv Cancer Res contributor: fullname: Debatin, KM – volume: 8 start-page: 2553 year: 2002 end-page: 2562 article-title: Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance publication-title: Clin Cancer Res contributor: fullname: Johnson, JT – volume: 192 start-page: 755 year: 2000 end-page: 760 article-title: Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma publication-title: J Exp Med contributor: fullname: Trapani, JA – volume: 10 start-page: 789 year: 2004 end-page: 799 article-title: Cancer genes and the pathways they control publication-title: Nat Med contributor: fullname: Kinzler, KW – volume: 198 start-page: 1741 year: 2003 end-page: 1752 article-title: Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence publication-title: J Exp Med contributor: fullname: Donaldson, DD – volume: 65 start-page: 1045 year: 2005a end-page: 1054 article-title: Cooperative disengagement of Fas and intercellular adhesion molecule-1 function in neoplastic cells confers enhanced colonization efficiency publication-title: Cancer Res contributor: fullname: Abrams, SI – volume: 5 start-page: 641 year: 2005 end-page: 654 article-title: Regulation of immune responses by -arginine metabolism publication-title: Nat Rev Immunol contributor: fullname: Zanovello, P – volume: 64 start-page: 6337 year: 2004 end-page: 6343 article-title: High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells publication-title: Cancer Res contributor: fullname: Borrello, I – volume: 56 start-page: 739 year: 2007 end-page: 745 article-title: Contribution of the PD-L1 PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion publication-title: Cancer Immunol Immunother contributor: fullname: Mackensen, A – volume: 25 start-page: 2546 year: 2007 end-page: 2553 article-title: Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine publication-title: J Clin Oncol contributor: fullname: Iero, M – volume: 170 start-page: 6329 year: 2003b end-page: 6337 article-title: Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-gamma publication-title: J Immunol contributor: fullname: Abrams, SI – volume: 4 start-page: 641 year: 2004 end-page: 648 article-title: Inflammation and necrosis promote tumour growth publication-title: Nat Rev Immunol contributor: fullname: Lotze, MT – volume: 9 start-page: 4404 year: 2003 end-page: 4408 article-title: Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers publication-title: Clin Cancer Res contributor: fullname: Fujii, H – volume: 4 start-page: 71 year: 2004 end-page: 78 article-title: Tumour-educated macrophages promote tumour progression and metastasis publication-title: Nat Rev Cancer contributor: fullname: Pollard, JW – volume: 6 start-page: 71 year: 2004 end-page: 77 article-title: Role of anti-CTLA-4 therapies in the treatment of cancer publication-title: Curr Opin Mol Ther contributor: fullname: Abrams, SI – volume: 12 start-page: 3381 year: 2006 end-page: 3388 article-title: A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer publication-title: Clin Cancer Res contributor: fullname: Tucker, C – volume: 298 start-page: 850 year: 2002 end-page: 854 article-title: Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes publication-title: Science contributor: fullname: Schwartzentruber, DJ – volume: 13 start-page: 721s year: 2007 end-page: 726s article-title: Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma publication-title: Clin Cancer Res contributor: fullname: Rodriguez, PC – volume: 21 start-page: 807 year: 2003 end-page: 839 article-title: Does the immune system see tumors as foreign or self? publication-title: Annu Rev Immunol contributor: fullname: Pardoll, D – volume: 21 start-page: 685 year: 2003 end-page: 711 article-title: Tolerogenic dendritic cells publication-title: Annu Rev Immunol contributor: fullname: Nussenzweig, MC – volume: 169 start-page: 2756 year: 2002 end-page: 2761 article-title: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma publication-title: J Immunol contributor: fullname: Doherty, G – volume: 90 start-page: 1 year: 2006 end-page: 50 article-title: Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity publication-title: Adv Immunol contributor: fullname: Schreiber, RD – volume: 1 start-page: 515 year: 2000 end-page: 520 article-title: NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway publication-title: Nat Immunol contributor: fullname: Donaldson, DD – volume: 67 start-page: 5064 year: 2007 end-page: 5066 article-title: Tumor-associated macrophages press the angiogenic switch in breast cancer publication-title: Cancer Res contributor: fullname: Pollard, JW – volume: 176 start-page: 3402 year: 2006 end-page: 3409 article-title: Role of antigen-processing machinery in the resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL publication-title: J Immunol contributor: fullname: DeLeo, AB – volume: 111 start-page: 69 year: 2007 end-page: 75 article-title: Tumor immune escape mediated by indoleamine 2,3-dioxygenase publication-title: Immunol Lett contributor: fullname: Karanikas, V – volume: 103 start-page: 10391 year: 2006 end-page: 10396 article-title: B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival publication-title: Proc Natl Acad Sci USA contributor: fullname: Kuntz, SM – volume: 100 start-page: 57 year: 2000 end-page: 70 article-title: The hallmarks of cancer publication-title: Cell contributor: fullname: Weinberg, RA – volume: 61 start-page: 4756 year: 2001 end-page: 4760 article-title: Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients publication-title: Cancer Res contributor: fullname: Finn, OJ – volume: 65 start-page: 3044 year: 2005 end-page: 3048 article-title: Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion publication-title: Cancer Res contributor: fullname: Zabaleta, J – volume: 90 start-page: 297 year: 2006 end-page: 339 article-title: Checkpoint blockade in cancer immunotherapy publication-title: Adv Immunol contributor: fullname: Allison, JP – volume: 12 start-page: 3890 year: 2006 end-page: 3895 article-title: Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer publication-title: Clin Cancer Res contributor: fullname: Ferrone, S – volume: 23 start-page: 330 year: 2002 end-page: 332 article-title: Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes' publication-title: Trends Immunol contributor: fullname: Caruso, C – volume: 190 start-page: 355 year: 1999 end-page: 366 article-title: Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation publication-title: J Exp Med contributor: fullname: Allison, JP – volume: 163 start-page: 4886 year: 1999 end-page: 4893 article-title: A 'stealth effect': adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions publication-title: J Immunol contributor: fullname: Kim, Y – volume: 58 start-page: 526 year: 1998 end-page: 534 article-title: Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis publication-title: Cancer Res contributor: fullname: Moller, P – volume: 176 start-page: 3374 year: 2006 end-page: 3382 article-title: CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape publication-title: J Immunol contributor: fullname: Abrams, SI – volume: 27 start-page: 611 year: 2005 end-page: 615 article-title: Fas expression in lung metastasis from osteosarcoma patients publication-title: J Pediatr Hematol Oncol contributor: fullname: Munsell, MF – volume: 10 start-page: 3755 year: 2004 end-page: 3762 article-title: Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck publication-title: Clin Cancer Res contributor: fullname: Whiteside, TL – volume: 22 start-page: 531 year: 2004 end-page: 562 article-title: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses publication-title: Annu Rev Immunol contributor: fullname: Sakaguchi, S – volume: 67 start-page: 5454 year: 2007 end-page: 5460 article-title: Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma publication-title: Cancer Res contributor: fullname: Musiani, P – volume: 437 start-page: 141 year: 2005 end-page: 146 article-title: Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance publication-title: Nature contributor: fullname: Blankenstein, T – volume: 13 start-page: 4840 year: 2007 end-page: 4848 article-title: Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses publication-title: Clin Cancer Res contributor: fullname: Lee, JH – volume: 107 start-page: 5 year: 2002 end-page: 9 article-title: Regulation of tumour immunity by CD25+ T cells publication-title: Immunology contributor: fullname: Sakaguchi, S – volume: 202 start-page: 931 year: 2005 end-page: 939 article-title: Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma publication-title: J Exp Med contributor: fullname: Ochoa, JB – volume: 203 start-page: 871 year: 2006 end-page: 881 article-title: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma publication-title: J Exp Med contributor: fullname: Mottram, P – volume: 117 start-page: 1167 year: 2007 end-page: 1174 article-title: Tregs and rethinking cancer immunotherapy publication-title: J Clin Invest contributor: fullname: Curiel, TJ – volume: 56 start-page: 4791 year: 1996 end-page: 4798 article-title: Fas expression and function in normal and malignant breast cell lines publication-title: Cancer Res contributor: fullname: Lipkowitz, S – volume: 170 start-page: 5973 year: 2003a end-page: 5980 article-title: Alterations in Fas expression are characteristic of, but not solely responsible for, enhanced metastatic competence publication-title: J Immunol contributor: fullname: Abrams, SI – volume: 198 start-page: 569 year: 2003 end-page: 580 article-title: Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells publication-title: J Exp Med contributor: fullname: Vyth-Dreese, FA – volume: 3 start-page: 666 year: 2003 end-page: 675 article-title: Adoptive-cell-transfer therapy for the treatment of patients with cancer publication-title: Nat Rev Cancer contributor: fullname: Rosenberg, SA – volume: 61 start-page: 4766 year: 2001 end-page: 4772 article-title: Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer publication-title: Cancer Res contributor: fullname: Coukos, G – volume: 100 start-page: 2281 year: 2004 end-page: 2291 article-title: The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy publication-title: Cancer contributor: fullname: Toge, T – volume: 201 start-page: 1591 year: 2005 end-page: 1602 article-title: Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response publication-title: J Exp Med contributor: fullname: Machiels, JP – volume: 36 start-page: 561 year: 2004 end-page: 565 article-title: Histological expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in human primary melanoma publication-title: Pathology contributor: fullname: Hersey, P – volume: 31 start-page: 1260 year: 1999 end-page: 1262 article-title: Posttransplant malignancies publication-title: Transplant Proc contributor: fullname: Penn, I – volume: 99 start-page: 12293 year: 2002 end-page: 12297 article-title: Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade publication-title: Proc Natl Acad Sci USA contributor: fullname: Minato, N – volume: 251 start-page: 1228 year: 1991 end-page: 1231 article-title: Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production publication-title: Science contributor: fullname: Germain, RN – volume: 56 start-page: 227 year: 2007 end-page: 236 article-title: Immune selective pressure and HLA class I antigen defects in malignant lesions publication-title: Cancer Immunol Immunother contributor: fullname: Ferrone, S – volume: 8 start-page: 369 year: 2005 end-page: 380 article-title: TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance publication-title: Cancer Cell contributor: fullname: Massague, J – volume: 11 start-page: 728 year: 2005 end-page: 734 article-title: Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer publication-title: Clin Cancer Res contributor: fullname: Allison, JP – volume: 291 start-page: 319 year: 2001 end-page: 322 article-title: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice publication-title: Science contributor: fullname: Matsumori, A – volume: 271 start-page: 1734 year: 1996 end-page: 1736 article-title: Enhancement of antitumor immunity by CTLA-4 blockade publication-title: Science contributor: fullname: Allison, JP – volume: 66 start-page: 9299 year: 2006 end-page: 9307 article-title: All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients publication-title: Cancer Res contributor: fullname: Frost, TJ – volume: 65 start-page: 2457 year: 2005 end-page: 2464 article-title: Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma publication-title: Cancer Res contributor: fullname: Korangy, F – volume: 11 start-page: 2947 year: 2005 end-page: 2953 article-title: Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer publication-title: Clin Cancer Res contributor: fullname: Ikeda, N – volume: 87 start-page: 33 year: 2004 end-page: 44 article-title: Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis publication-title: Breast Cancer Res Treat contributor: fullname: Sierra, A – volume: 18 start-page: 423 year: 2000 end-page: 449 article-title: Regulatory T cells in autoimmmunity publication-title: Annu Rev Immunol contributor: fullname: Shevach, EM – volume: 24 start-page: 99 year: 2006 end-page: 146 article-title: Transforming growth factor-beta regulation of immune responses publication-title: Annu Rev Immunol contributor: fullname: Flavell, RA – volume: 10 start-page: 942 year: 2004 end-page: 949 article-title: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival publication-title: Nat Med contributor: fullname: Mottram, P – volume: 55 start-page: 237 year: 2006 end-page: 245 article-title: Role of immature myeloid cells in mechanisms of immune evasion in cancer publication-title: Cancer Immunol Immunother contributor: fullname: Gabrilovich, DI – volume: 107 start-page: 628 year: 2006 end-page: 636 article-title: Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines publication-title: Blood contributor: fullname: Levitsky, HI – volume: 11 start-page: 1314 year: 2005 end-page: 1321 article-title: Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity publication-title: Nat Med contributor: fullname: Pilon-Thomas, S – volume: 35 start-page: 1812 year: 2005 end-page: 1821 article-title: Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L TRAIL publication-title: Eur J Immunol contributor: fullname: Marzo, I – volume: 67 start-page: 4507 year: 2007 end-page: 4513 article-title: Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells publication-title: Cancer Res contributor: fullname: Ostrand-Rosenberg, S – volume: 65 start-page: 1089 year: 2005 end-page: 1096 article-title: Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity publication-title: Cancer Res contributor: fullname: Ichikawa, M – volume: 63 start-page: 9007 year: 2003 end-page: 9015 article-title: Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens publication-title: Cancer Res contributor: fullname: Gu, L – volume: 66 start-page: 3381 year: 2006 end-page: 3385 article-title: Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up publication-title: Cancer Res contributor: fullname: Webster, WS – volume: 16 start-page: 3 year: 2006 end-page: 15 article-title: Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention publication-title: Semin Cancer Biol contributor: fullname: Whiteside, TL – volume: 6 start-page: 836 year: 2006 end-page: 848 article-title: Interferons, immunity and cancer immunoediting publication-title: Nat Rev Immunol contributor: fullname: Schreiber, RD – volume: 13 start-page: 99 year: 2004 end-page: 104 article-title: TGF-beta1 inhibits Fas-mediated apoptosis by regulating surface Fas and cFLIPL expression in human leukaemia lymphoma cells publication-title: Int J Mol Med contributor: fullname: Park, JH – volume: 13 start-page: 4016 year: 2007 end-page: 4025 article-title: Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy publication-title: Clin Cancer Res contributor: fullname: Hu, P – volume: 65 start-page: 4376 year: 2005b end-page: 4388 article-title: Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression publication-title: Cancer Res contributor: fullname: Abrams, SI – volume: 7 start-page: 94 year: 2001 end-page: 100 article-title: Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells publication-title: Nat Med contributor: fullname: Kakuta, S – volume: 9 start-page: 1 year: 2007 end-page: 20 article-title: Immunological responses can have both pro- and antitumour effects: implications for immunotherapy publication-title: Exp Rev Mol Med contributor: fullname: Abrams, SI – volume: 19 start-page: 203 year: 2007 end-page: 208 article-title: Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? publication-title: Curr Opin Immunol contributor: fullname: Schreiber, RD – volume: 10 start-page: 48 year: 2004 end-page: 54 article-title: Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells publication-title: Nat Med contributor: fullname: Zhang, S – volume: 2 start-page: 261 year: 2001 end-page: 268 article-title: PD-L2 is a second ligand for PD-1 and inhibits T cell activation publication-title: Nat Immunol contributor: fullname: Chernova, I – volume: 195 start-page: 1303 year: 2002 end-page: 1316 article-title: Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles publication-title: J Exp Med contributor: fullname: Deho, P – volume: 11 start-page: 6713 year: 2005 end-page: 6721 article-title: Gemcitabine selectively eliminates splenic Gr-1+ CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity publication-title: Clin Cancer Res contributor: fullname: Albelda, SM – volume: 110 start-page: 3192 year: 2007 end-page: 3201 article-title: The IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity publication-title: Blood contributor: fullname: Palena, C – volume: 30 start-page: 251 year: 2007 end-page: 260 article-title: The new B7s: playing a pivotal role in tumor immunity publication-title: J Immunother (1997) contributor: fullname: Chen, L – volume: 209 start-page: 19 year: 2001 end-page: 28 article-title: Dendritic cells issued from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells publication-title: Cell Immunol contributor: fullname: Gualde, N – volume: 100 start-page: 8372 year: 2003 end-page: 8377 article-title: Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma publication-title: Proc Natl Acad Sci USA contributor: fullname: Schwartzentruber, DJ – volume: 17 start-page: 5 year: 2000 end-page: 12 article-title: Fas and Fas ligand interactions in malignant disease publication-title: Int J Oncol contributor: fullname: Hill, LL – volume: 5 start-page: 677 year: 1999 end-page: 685 article-title: Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients publication-title: Nat Med contributor: fullname: Weber, JS – volume: 67 start-page: 10406 year: 2007 end-page: 10416 article-title: Host immunosurveillance controls tumor growth via IRF-8-dependent mechanisms publication-title: Cancer Res contributor: fullname: Liu, K – volume: 9 start-page: 823 year: 2002 end-page: 827 article-title: Fas expression inversely correlates with metastatic potential in osteosarcoma cells publication-title: Oncol Rep contributor: fullname: Kleinerman, ES – volume: 166 start-page: 678 year: 2001 end-page: 689 article-title: Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer publication-title: J Immunol contributor: fullname: Knight, SC – volume: 87 start-page: 307 year: 1996 end-page: 317 article-title: Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene publication-title: Cell contributor: fullname: Rosenbauer, F – volume: 67 start-page: 3301 year: 2007 end-page: 3309 article-title: Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells publication-title: Cancer Res contributor: fullname: Tamura, T – volume: 171 start-page: 4164 year: 2003 end-page: 4174 article-title: Exposure of human primary colon carcinoma cells to anti-Fas interactions influences the emergence of pre-existing Fas-resistant metastatic subpopulations publication-title: J Immunol contributor: fullname: Abrams, SI – volume: 18 start-page: 849 year: 2003 end-page: 861 article-title: B7-H4, a molecule of the B7 family, negatively regulates T cell immunity publication-title: Immunity contributor: fullname: Tamura, H – volume: 6 start-page: 409 year: 2004 end-page: 421 article-title: Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis publication-title: Cancer Cell contributor: fullname: Shyr, Y – volume: 174 start-page: 1830 year: 2005 end-page: 1840 article-title: Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function publication-title: J Immunol contributor: fullname: Frey, AB – volume: 601 start-page: 213 year: 2007 end-page: 223 article-title: Myeloid-derived suppressor cells publication-title: Adv Exp Med Biol contributor: fullname: Gabrilovich, DI – volume: 7 start-page: 41 year: 2007 end-page: 51 article-title: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment publication-title: Nat Rev Immunol contributor: fullname: Pardoll, D – volume: 5 start-page: 641 year: 2005 end-page: 654 ident: CR7 article-title: Regulation of immune responses by -arginine metabolism publication-title: Nat Rev Immunol doi: 10.1038/nri1668 contributor: fullname: Zanovello – volume: 21 start-page: 685 year: 2003 end-page: 711 ident: CR86 article-title: Tolerogenic dendritic cells publication-title: Annu Rev Immunol contributor: fullname: Nussenzweig – volume: 291 start-page: 319 year: 2001 end-page: 322 ident: CR62 article-title: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice publication-title: Science contributor: fullname: Matsumori – volume: 176 start-page: 3402 year: 2006 end-page: 3409 ident: CR59 article-title: Role of antigen-processing machinery in the resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL publication-title: J Immunol contributor: fullname: DeLeo – volume: 10 start-page: 789 year: 2004 end-page: 799 ident: CR97 article-title: Cancer genes and the pathways they control publication-title: Nat Med contributor: fullname: Kinzler – volume: 6 start-page: 836 year: 2006 end-page: 848 ident: CR16 article-title: Interferons, immunity and cancer immunoediting publication-title: Nat Rev Immunol contributor: fullname: Schreiber – volume: 58 start-page: 526 year: 1998 end-page: 534 ident: CR98 article-title: Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis publication-title: Cancer Res contributor: fullname: Moller – volume: 61 start-page: 4766 year: 2001 end-page: 4772 ident: CR102 article-title: Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer publication-title: Cancer Res contributor: fullname: Coukos – volume: 169 start-page: 2756 year: 2002 end-page: 2761 ident: CR58 article-title: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma publication-title: J Immunol contributor: fullname: Doherty – volume: 103 start-page: 10391 year: 2006 end-page: 10396 ident: CR41 article-title: B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival publication-title: Proc Natl Acad Sci USA contributor: fullname: Kuntz – volume: 202 start-page: 931 year: 2005 end-page: 939 ident: CR76 article-title: Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma publication-title: J Exp Med contributor: fullname: Ochoa – volume: 63 start-page: 9007 year: 2003 end-page: 9015 ident: CR10 article-title: Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens publication-title: Cancer Res contributor: fullname: Gu – volume: 601 start-page: 213 year: 2007 end-page: 223 ident: CR61 article-title: Myeloid-derived suppressor cells publication-title: Adv Exp Med Biol contributor: fullname: Gabrilovich – volume: 437 start-page: 141 year: 2005 end-page: 146 ident: CR101 article-title: Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance publication-title: Nature contributor: fullname: Blankenstein – volume: 11 start-page: 6713 year: 2005 end-page: 6721 ident: CR89 article-title: Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity publication-title: Clin Cancer Res contributor: fullname: Albelda – volume: 8 start-page: 2553 year: 2002 end-page: 2562 ident: CR31 article-title: Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance publication-title: Clin Cancer Res contributor: fullname: Johnson – volume: 99 start-page: 12293 year: 2002 end-page: 12297 ident: CR34 article-title: Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade publication-title: Proc Natl Acad Sci USA contributor: fullname: Minato – volume: 67 start-page: 5064 year: 2007 end-page: 5066 ident: CR50 article-title: Tumor-associated macrophages press the angiogenic switch in breast cancer publication-title: Cancer Res contributor: fullname: Pollard – volume: 64 start-page: 6337 year: 2004 end-page: 6343 ident: CR80 article-title: High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells publication-title: Cancer Res contributor: fullname: Borrello – volume: 90 start-page: 1 year: 2006 end-page: 50 ident: CR84 article-title: Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity publication-title: Adv Immunol contributor: fullname: Schreiber – volume: 166 start-page: 678 year: 2001 end-page: 689 ident: CR2 article-title: Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer publication-title: J Immunol contributor: fullname: Knight – volume: 90 start-page: 297 year: 2006 end-page: 339 ident: CR39 article-title: Checkpoint blockade in cancer immunotherapy publication-title: Adv Immunol contributor: fullname: Allison – volume: 2 start-page: 261 year: 2001 end-page: 268 ident: CR46 article-title: PD-L2 is a second ligand for PD-1 and inhibits T cell activation publication-title: Nat Immunol contributor: fullname: Chernova – volume: 35 start-page: 1812 year: 2005 end-page: 1821 ident: CR5 article-title: Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL publication-title: Eur J Immunol contributor: fullname: Marzo – volume: 9 start-page: 1 year: 2007 end-page: 20 ident: CR87 article-title: Immunological responses can have both pro- and antitumour effects: implications for immunotherapy publication-title: Exp Rev Mol Med contributor: fullname: Abrams – volume: 12 start-page: 3381 year: 2006 end-page: 3388 ident: CR75 article-title: A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer publication-title: Clin Cancer Res contributor: fullname: Tucker – volume: 55 start-page: 237 year: 2006 end-page: 245 ident: CR44 article-title: Role of immature myeloid cells in mechanisms of immune evasion in cancer publication-title: Cancer Immunol Immunother contributor: fullname: Gabrilovich – volume: 10 start-page: 3755 year: 2004 end-page: 3762 ident: CR45 article-title: Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck publication-title: Clin Cancer Res contributor: fullname: Whiteside – volume: 174 start-page: 1830 year: 2005 end-page: 1840 ident: CR38 article-title: Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function publication-title: J Immunol contributor: fullname: Frey – volume: 107 start-page: 5 year: 2002 end-page: 9 ident: CR24 article-title: Regulation of tumour immunity by CD25+ T cells publication-title: Immunology contributor: fullname: Sakaguchi – volume: 251 start-page: 1228 year: 1991 end-page: 1231 ident: CR67 article-title: Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production publication-title: Science contributor: fullname: Germain – volume: 170 start-page: 6329 year: 2003 end-page: 6337 ident: CR53 article-title: Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-gamma publication-title: J Immunol contributor: fullname: Abrams – volume: 19 start-page: 203 year: 2007 end-page: 208 ident: CR8 article-title: Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? publication-title: Curr Opin Immunol contributor: fullname: Schreiber – volume: 31 start-page: 1260 year: 1999 end-page: 1262 ident: CR72 article-title: Posttransplant malignancies publication-title: Transplant Proc contributor: fullname: Penn – volume: 66 start-page: 3381 year: 2006 end-page: 3385 ident: CR94 article-title: Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up publication-title: Cancer Res contributor: fullname: Webster – volume: 65 start-page: 1045 year: 2005 end-page: 1054 ident: CR54 article-title: Cooperative disengagement of Fas and intercellular adhesion molecule-1 function in neoplastic cells confers enhanced colonization efficiency publication-title: Cancer Res contributor: fullname: Abrams – volume: 23 start-page: 330 year: 2002 end-page: 332 ident: CR71 article-title: Is human immunosenescence clinically relevant? Looking for ‘immunological risk phenotypes’ publication-title: Trends Immunol contributor: fullname: Caruso – volume: 13 start-page: 4016 year: 2007 end-page: 4025 ident: CR77 article-title: Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy publication-title: Clin Cancer Res contributor: fullname: Hu – volume: 8 start-page: 369 year: 2005 end-page: 380 ident: CR93 article-title: TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance publication-title: Cancer Cell contributor: fullname: Massague – volume: 66 start-page: 9299 year: 2006 end-page: 9307 ident: CR60 article-title: All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients publication-title: Cancer Res contributor: fullname: Frost – volume: 110 start-page: 3192 year: 2007 end-page: 3201 ident: CR51 article-title: The IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity publication-title: Blood contributor: fullname: Palena – volume: 13 start-page: 721s year: 2007 end-page: 726s ident: CR63 article-title: Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma publication-title: Clin Cancer Res contributor: fullname: Rodriguez – volume: 198 start-page: 569 year: 2003 end-page: 580 ident: CR68 article-title: Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells publication-title: J Exp Med contributor: fullname: Vyth-Dreese – volume: 100 start-page: 8372 year: 2003 end-page: 8377 ident: CR73 article-title: Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma publication-title: Proc Natl Acad Sci USA contributor: fullname: Schwartzentruber – volume: 163 start-page: 4886 year: 1999 end-page: 4893 ident: CR25 article-title: A ‘stealth effect’: adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions publication-title: J Immunol contributor: fullname: Kim – volume: 100 start-page: 2281 year: 2004 end-page: 2291 ident: CR37 article-title: The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy publication-title: Cancer contributor: fullname: Toge – volume: 190 start-page: 355 year: 1999 end-page: 366 ident: CR96 article-title: Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation publication-title: J Exp Med contributor: fullname: Allison – volume: 17 start-page: 5 year: 2000 end-page: 12 ident: CR69 article-title: Fas and Fas ligand interactions in malignant disease publication-title: Int J Oncol contributor: fullname: Hill – volume: 56 start-page: 739 year: 2007 end-page: 745 ident: CR4 article-title: Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion publication-title: Cancer Immunol Immunother contributor: fullname: Mackensen – volume: 65 start-page: 4376 year: 2005 end-page: 4388 ident: CR55 article-title: Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression publication-title: Cancer Res contributor: fullname: Abrams – volume: 201 start-page: 1591 year: 2005 end-page: 1602 ident: CR17 article-title: Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response publication-title: J Exp Med contributor: fullname: Machiels – volume: 117 start-page: 1167 year: 2007 end-page: 1174 ident: CR11 article-title: Tregs and rethinking cancer immunotherapy publication-title: J Clin Invest contributor: fullname: Curiel – volume: 100 start-page: 57 year: 2000 end-page: 70 ident: CR28 article-title: The hallmarks of cancer publication-title: Cell contributor: fullname: Weinberg – volume: 5 start-page: 677 year: 1999 end-page: 685 ident: CR48 article-title: Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients publication-title: Nat Med contributor: fullname: Weber – volume: 171 start-page: 4164 year: 2003 end-page: 4174 ident: CR57 article-title: Exposure of human primary colon carcinoma cells to anti-Fas interactions influences the emergence of pre-existing Fas-resistant metastatic subpopulations publication-title: J Immunol contributor: fullname: Abrams – volume: 9 start-page: 4404 year: 2003 end-page: 4408 ident: CR33 article-title: Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers publication-title: Clin Cancer Res contributor: fullname: Fujii – volume: 198 start-page: 1741 year: 2003 end-page: 1752 ident: CR92 article-title: Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence publication-title: J Exp Med contributor: fullname: Donaldson – volume: 75 start-page: 251 year: 1998 end-page: 273 ident: CR42 article-title: CD95(APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells publication-title: Adv Cancer Res contributor: fullname: Debatin – volume: 10 start-page: 942 year: 2004 end-page: 949 ident: CR12 article-title: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival publication-title: Nat Med contributor: fullname: Mottram – volume: 192 start-page: 755 year: 2000 end-page: 760 ident: CR85 article-title: Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma publication-title: J Exp Med contributor: fullname: Trapani – volume: 65 start-page: 2457 year: 2005 end-page: 2464 ident: CR66 article-title: Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma publication-title: Cancer Res contributor: fullname: Korangy – volume: 56 start-page: 227 year: 2007 end-page: 236 ident: CR9 article-title: Immune selective pressure and HLA class I antigen defects in malignant lesions publication-title: Cancer Immunol Immunother contributor: fullname: Ferrone – volume: 13 start-page: 99 year: 2004 end-page: 104 ident: CR35 article-title: TGF-beta1 inhibits Fas-mediated apoptosis by regulating surface Fas and cFLIPL expression in human leukaemia/lymphoma cells publication-title: Int J Mol Med contributor: fullname: Park – volume: 3 start-page: 666 year: 2003 end-page: 675 ident: CR14 article-title: Adoptive-cell-transfer therapy for the treatment of patients with cancer publication-title: Nat Rev Cancer contributor: fullname: Rosenberg – volume: 13 start-page: 4840 year: 2007 end-page: 4848 ident: CR23 article-title: Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses publication-title: Clin Cancer Res contributor: fullname: Lee – volume: 22 start-page: 531 year: 2004 end-page: 562 ident: CR78 article-title: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses publication-title: Annu Rev Immunol contributor: fullname: Sakaguchi – volume: 107 start-page: 628 year: 2006 end-page: 636 ident: CR109 article-title: Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines publication-title: Blood contributor: fullname: Levitsky – volume: 7 start-page: 94 year: 2001 end-page: 100 ident: CR90 article-title: Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells publication-title: Nat Med contributor: fullname: Kakuta – volume: 271 start-page: 1734 year: 1996 end-page: 1736 ident: CR47 article-title: Enhancement of antitumor immunity by CTLA-4 blockade publication-title: Science contributor: fullname: Allison – volume: 65 start-page: 1089 year: 2005 end-page: 1096 ident: CR30 article-title: Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity publication-title: Cancer Res contributor: fullname: Ichikawa – volume: 11 start-page: 2947 year: 2005 end-page: 2953 ident: CR65 article-title: Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer publication-title: Clin Cancer Res contributor: fullname: Ikeda – volume: 195 start-page: 1303 year: 2002 end-page: 1316 ident: CR3 article-title: Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles publication-title: J Exp Med contributor: fullname: Deho – volume: 10 start-page: 48 year: 2004 end-page: 54 ident: CR99 article-title: Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells publication-title: Nat Med contributor: fullname: Zhang – volume: 25 start-page: 2546 year: 2007 end-page: 2553 ident: CR20 article-title: Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine publication-title: J Clin Oncol contributor: fullname: Iero – volume: 9 start-page: 823 year: 2002 end-page: 827 ident: CR103 article-title: Fas expression inversely correlates with metastatic potential in osteosarcoma cells publication-title: Oncol Rep contributor: fullname: Kleinerman – volume: 11 start-page: 728 year: 2005 end-page: 734 ident: CR13 article-title: Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer publication-title: Clin Cancer Res contributor: fullname: Allison – volume: 11 start-page: 1314 year: 2005 end-page: 1321 ident: CR40 article-title: Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity publication-title: Nat Med contributor: fullname: Pilon-Thomas – volume: 56 start-page: 4791 year: 1996 end-page: 4798 ident: CR36 article-title: Fas expression and function in normal and malignant breast cell lines publication-title: Cancer Res contributor: fullname: Lipkowitz – volume: 203 start-page: 871 year: 2006 end-page: 881 ident: CR43 article-title: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma publication-title: J Exp Med contributor: fullname: Mottram – volume: 67 start-page: 5454 year: 2007 end-page: 5460 ident: CR88 article-title: Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma publication-title: Cancer Res contributor: fullname: Musiani – volume: 87 start-page: 33 year: 2004 end-page: 44 ident: CR18 article-title: Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis publication-title: Breast Cancer Res Treat contributor: fullname: Sierra – volume: 209 start-page: 19 year: 2001 end-page: 28 ident: CR29 article-title: Dendritic cells issued from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells publication-title: Cell Immunol contributor: fullname: Gualde – volume: 170 start-page: 5973 year: 2003 end-page: 5980 ident: CR52 article-title: Alterations in Fas expression are characteristic of, but not solely responsible for, enhanced metastatic competence publication-title: J Immunol contributor: fullname: Abrams – volume: 61 start-page: 4756 year: 2001 end-page: 4760 ident: CR79 article-title: Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients publication-title: Cancer Res contributor: fullname: Finn – volume: 1 start-page: 515 year: 2000 end-page: 520 ident: CR91 article-title: NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway publication-title: Nat Immunol contributor: fullname: Donaldson – volume: 27 start-page: 611 year: 2005 end-page: 615 ident: CR26 article-title: Fas expression in lung metastasis from osteosarcoma patients publication-title: J Pediatr Hematol Oncol contributor: fullname: Munsell – volume: 18 start-page: 423 year: 2000 end-page: 449 ident: CR81 article-title: Regulatory T cells in autoimmmunity publication-title: Annu Rev Immunol contributor: fullname: Shevach – volume: 67 start-page: 3301 year: 2007 end-page: 3309 ident: CR104 article-title: Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells publication-title: Cancer Res contributor: fullname: Tamura – volume: 16 start-page: 3 year: 2006 end-page: 15 ident: CR100 article-title: Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention publication-title: Semin Cancer Biol contributor: fullname: Whiteside – volume: 67 start-page: 4507 year: 2007 end-page: 4513 ident: CR83 article-title: Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells publication-title: Cancer Res contributor: fullname: Ostrand-Rosenberg – volume: 6 start-page: 71 year: 2004 end-page: 77 ident: CR1 article-title: Role of anti-CTLA-4 therapies in the treatment of cancer publication-title: Curr Opin Mol Ther contributor: fullname: Abrams – volume: 30 start-page: 251 year: 2007 end-page: 260 ident: CR21 article-title: The new B7s: playing a pivotal role in tumor immunity publication-title: J Immunother (1997) contributor: fullname: Chen – volume: 87 start-page: 307 year: 1996 end-page: 317 ident: CR32 article-title: Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene publication-title: Cell contributor: fullname: Rosenbauer – volume: 4 start-page: 71 year: 2004 end-page: 78 ident: CR74 article-title: Tumour-educated macrophages promote tumour progression and metastasis publication-title: Nat Rev Cancer contributor: fullname: Pollard – volume: 21 start-page: 807 year: 2003 end-page: 839 ident: CR70 article-title: Does the immune system see tumors as foreign or self? publication-title: Annu Rev Immunol contributor: fullname: Pardoll – volume: 7 start-page: 41 year: 2007 end-page: 51 ident: CR106 article-title: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment publication-title: Nat Rev Immunol contributor: fullname: Pardoll – volume: 96 start-page: 2233 year: 1999 end-page: 2238 ident: CR64 article-title: Immune surveillance against a solid tumor fails because of immunological ignorance publication-title: Proc Natl Acad Sci USA contributor: fullname: Hengartner – volume: 65 start-page: 3044 year: 2005 end-page: 3048 ident: CR108 article-title: Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion publication-title: Cancer Res contributor: fullname: Zabaleta – volume: 12 start-page: 3890 year: 2006 end-page: 3895 ident: CR19 article-title: Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer publication-title: Clin Cancer Res contributor: fullname: Ferrone – volume: 67 start-page: 10406 year: 2007 end-page: 10416 ident: CR27 article-title: Host immunosurveillance controls tumor growth via IRF-8-dependent mechanisms publication-title: Cancer Res contributor: fullname: Liu – volume: 18 start-page: 849 year: 2003 end-page: 861 ident: CR82 article-title: B7-H4, a molecule of the B7 family, negatively regulates T cell immunity publication-title: Immunity contributor: fullname: Tamura – volume: 176 start-page: 3374 year: 2006 end-page: 3382 ident: CR56 article-title: CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape publication-title: J Immunol contributor: fullname: Abrams – volume: 36 start-page: 561 year: 2004 end-page: 565 ident: CR6 article-title: Histological expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in human primary melanoma publication-title: Pathology contributor: fullname: Hersey – volume: 298 start-page: 850 year: 2002 end-page: 854 ident: CR15 article-title: Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes publication-title: Science doi: 10.1126/science.1076514 contributor: fullname: Schwartzentruber – volume: 4 start-page: 641 year: 2004 end-page: 648 ident: CR95 article-title: Inflammation and necrosis promote tumour growth publication-title: Nat Rev Immunol contributor: fullname: Lotze – volume: 6 start-page: 409 year: 2004 end-page: 421 ident: CR105 article-title: Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis publication-title: Cancer Cell contributor: fullname: Shyr – volume: 24 start-page: 99 year: 2006 end-page: 146 ident: CR49 article-title: Transforming growth factor-beta regulation of immune responses publication-title: Annu Rev Immunol contributor: fullname: Flavell – volume: 111 start-page: 69 year: 2007 end-page: 75 ident: CR107 article-title: Tumor immune escape mediated by indoleamine 2,3-dioxygenase publication-title: Immunol Lett contributor: fullname: Karanikas – volume: 192 start-page: 1027 year: 2000 end-page: 1034 ident: CR22 article-title: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation publication-title: J Exp Med contributor: fullname: Nishimura – volume: 9 start-page: 823 year: 2002 ident: BFonc2008268_CR103 publication-title: Oncol Rep contributor: fullname: LL Worth – volume: 10 start-page: 3755 year: 2004 ident: BFonc2008268_CR45 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-04-0054 contributor: fullname: I Kuss – volume: 291 start-page: 319 year: 2001 ident: BFonc2008268_CR62 publication-title: Science doi: 10.1126/science.291.5502.319 contributor: fullname: H Nishimura – volume: 8 start-page: 2553 year: 2002 ident: BFonc2008268_CR31 publication-title: Clin Cancer Res contributor: fullname: TK Hoffmann – volume: 25 start-page: 2546 year: 2007 ident: BFonc2008268_CR20 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.5829 contributor: fullname: P Filipazzi – volume: 192 start-page: 755 year: 2000 ident: BFonc2008268_CR85 publication-title: J Exp Med doi: 10.1084/jem.192.5.755 contributor: fullname: MJ Smyth – volume: 171 start-page: 4164 year: 2003 ident: BFonc2008268_CR57 publication-title: J Immunol doi: 10.4049/jimmunol.171.8.4164 contributor: fullname: K Liu – volume: 24 start-page: 99 year: 2006 ident: BFonc2008268_CR49 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.24.021605.090737 contributor: fullname: MO Li – volume: 67 start-page: 3301 year: 2007 ident: BFonc2008268_CR104 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-4068 contributor: fullname: D Yang – volume: 63 start-page: 9007 year: 2003 ident: BFonc2008268_CR10 publication-title: Cancer Res contributor: fullname: A Cuenca – volume: 36 start-page: 561 year: 2004 ident: BFonc2008268_CR6 publication-title: Pathology doi: 10.1080/00313020400011268 contributor: fullname: LP Bron – volume: 58 start-page: 526 year: 1998 ident: BFonc2008268_CR98 publication-title: Cancer Res contributor: fullname: U von Reyher – volume: 10 start-page: 48 year: 2004 ident: BFonc2008268_CR99 publication-title: Nat Med doi: 10.1038/nm976 contributor: fullname: T Wang – volume: 176 start-page: 3374 year: 2006 ident: BFonc2008268_CR56 publication-title: J Immunol doi: 10.4049/jimmunol.176.6.3374 contributor: fullname: K Liu – volume: 11 start-page: 2947 year: 2005 ident: BFonc2008268_CR65 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-04-1469 contributor: fullname: Y Ohigashi – volume: 4 start-page: 641 year: 2004 ident: BFonc2008268_CR95 publication-title: Nat Rev Immunol doi: 10.1038/nri1415 contributor: fullname: J Vakkila – volume: 190 start-page: 355 year: 1999 ident: BFonc2008268_CR96 publication-title: J Exp Med doi: 10.1084/jem.190.3.355 contributor: fullname: A van Elsas – volume: 11 start-page: 6713 year: 2005 ident: BFonc2008268_CR89 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-0883 contributor: fullname: E Suzuki – volume: 61 start-page: 4756 year: 2001 ident: BFonc2008268_CR79 publication-title: Cancer Res contributor: fullname: J Schmielau – volume: 87 start-page: 33 year: 2004 ident: BFonc2008268_CR18 publication-title: Breast Cancer Res Treat doi: 10.1023/B:BREA.0000041579.51902.89 contributor: fullname: L Espana – volume: 27 start-page: 611 year: 2005 ident: BFonc2008268_CR26 publication-title: J Pediatr Hematol Oncol doi: 10.1097/01.mph.0000188112.42576.df contributor: fullname: N Gordon – volume: 61 start-page: 4766 year: 2001 ident: BFonc2008268_CR102 publication-title: Cancer Res contributor: fullname: EY Woo – volume: 55 start-page: 237 year: 2006 ident: BFonc2008268_CR44 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-005-0048-z contributor: fullname: S Kusmartsev – volume: 12 start-page: 3381 year: 2006 ident: BFonc2008268_CR75 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-0112 contributor: fullname: KL Reckamp – volume: 1 start-page: 515 year: 2000 ident: BFonc2008268_CR91 publication-title: Nat Immunol doi: 10.1038/82771 contributor: fullname: M Terabe – volume: 6 start-page: 71 year: 2004 ident: BFonc2008268_CR1 publication-title: Curr Opin Mol Ther contributor: fullname: SI Abrams – volume: 170 start-page: 6329 year: 2003 ident: BFonc2008268_CR53 publication-title: J Immunol doi: 10.4049/jimmunol.170.12.6329 contributor: fullname: K Liu – volume: 7 start-page: 94 year: 2001 ident: BFonc2008268_CR90 publication-title: Nat Med doi: 10.1038/83416 contributor: fullname: K Takeda – volume: 103 start-page: 10391 year: 2006 ident: BFonc2008268_CR41 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0600937103 contributor: fullname: AE Krambeck – volume: 203 start-page: 871 year: 2006 ident: BFonc2008268_CR43 publication-title: J Exp Med doi: 10.1084/jem.20050930 contributor: fullname: I Kryczek – volume: 174 start-page: 1830 year: 2005 ident: BFonc2008268_CR38 publication-title: J Immunol doi: 10.4049/jimmunol.174.4.1830 contributor: fullname: M Koneru – volume: 99 start-page: 12293 year: 2002 ident: BFonc2008268_CR34 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.192461099 contributor: fullname: Y Iwai – volume: 66 start-page: 3381 year: 2006 ident: BFonc2008268_CR94 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-4303 contributor: fullname: RH Thompson – volume: 6 start-page: 836 year: 2006 ident: BFonc2008268_CR16 publication-title: Nat Rev Immunol doi: 10.1038/nri1961 contributor: fullname: GP Dunn – volume: 67 start-page: 10406 year: 2007 ident: BFonc2008268_CR27 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-1228 contributor: fullname: K Greeneltch – volume: 67 start-page: 5454 year: 2007 ident: BFonc2008268_CR88 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-4084 contributor: fullname: SE Street – volume: 65 start-page: 1045 year: 2005 ident: BFonc2008268_CR54 publication-title: Cancer Res doi: 10.1158/0008-5472.1045.65.3 contributor: fullname: K Liu – volume: 163 start-page: 4886 year: 1999 ident: BFonc2008268_CR25 publication-title: J Immunol doi: 10.4049/jimmunol.163.9.4886 contributor: fullname: M Giovarelli – volume: 17 start-page: 5 year: 2000 ident: BFonc2008268_CR69 publication-title: Int J Oncol contributor: fullname: L Owen-Schaub – volume: 107 start-page: 5 year: 2002 ident: BFonc2008268_CR24 publication-title: Immunology doi: 10.1046/j.1365-2567.2002.01471.x contributor: fullname: A Gallimore – volume: 8 start-page: 369 year: 2005 ident: BFonc2008268_CR93 publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.10.012 contributor: fullname: DA Thomas – volume: 176 start-page: 3402 year: 2006 ident: BFonc2008268_CR59 publication-title: J Immunol doi: 10.4049/jimmunol.176.6.3402 contributor: fullname: A Lopez-Albaitero – volume: 198 start-page: 569 year: 2003 ident: BFonc2008268_CR68 publication-title: J Exp Med doi: 10.1084/jem.20030590 contributor: fullname: WW Overwijk – volume: 21 start-page: 807 year: 2003 ident: BFonc2008268_CR70 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.21.120601.141135 contributor: fullname: D Pardoll – volume: 18 start-page: 849 year: 2003 ident: BFonc2008268_CR82 publication-title: Immunity doi: 10.1016/S1074-7613(03)00152-3 contributor: fullname: GL Sica – volume: 100 start-page: 57 year: 2000 ident: BFonc2008268_CR28 publication-title: Cell doi: 10.1016/S0092-8674(00)81683-9 contributor: fullname: D Hanahan – volume: 117 start-page: 1167 year: 2007 ident: BFonc2008268_CR11 publication-title: J Clin Invest doi: 10.1172/JCI31202 contributor: fullname: TJ Curiel – volume: 56 start-page: 4791 year: 1996 ident: BFonc2008268_CR36 publication-title: Cancer Res contributor: fullname: MM Keane – volume: 5 start-page: 641 year: 2005 ident: BFonc2008268_CR7 publication-title: Nat Rev Immunol doi: 10.1038/nri1668 contributor: fullname: V Bronte – volume: 90 start-page: 1 year: 2006 ident: BFonc2008268_CR84 publication-title: Adv Immunol doi: 10.1016/S0065-2776(06)90001-7 contributor: fullname: MJ Smyth – volume: 67 start-page: 4507 year: 2007 ident: BFonc2008268_CR83 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-4174 contributor: fullname: P Sinha – volume: 12 start-page: 3890 year: 2006 ident: BFonc2008268_CR19 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-2750 contributor: fullname: RL Ferris – volume: 90 start-page: 297 year: 2006 ident: BFonc2008268_CR39 publication-title: Adv Immunol doi: 10.1016/S0065-2776(06)90008-X contributor: fullname: AJ Korman – volume: 100 start-page: 8372 year: 2003 ident: BFonc2008268_CR73 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1533209100 contributor: fullname: GQ Phan – volume: 11 start-page: 728 year: 2005 ident: BFonc2008268_CR13 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.728.11.2 contributor: fullname: S Demaria – volume: 111 start-page: 69 year: 2007 ident: BFonc2008268_CR107 publication-title: Immunol Lett doi: 10.1016/j.imlet.2007.06.001 contributor: fullname: M Zamanakou – volume: 2 start-page: 261 year: 2001 ident: BFonc2008268_CR46 publication-title: Nat Immunol doi: 10.1038/85330 contributor: fullname: Y Latchman – volume: 35 start-page: 1812 year: 2005 ident: BFonc2008268_CR5 publication-title: Eur J Immunol doi: 10.1002/eji.200526046 contributor: fullname: A Bosque – volume: 169 start-page: 2756 year: 2002 ident: BFonc2008268_CR58 publication-title: J Immunol doi: 10.4049/jimmunol.169.5.2756 contributor: fullname: UK Liyanage – volume: 75 start-page: 251 year: 1998 ident: BFonc2008268_CR42 publication-title: Adv Cancer Res doi: 10.1016/S0065-230X(08)60744-7 contributor: fullname: PH Krammer – volume: 23 start-page: 330 year: 2002 ident: BFonc2008268_CR71 publication-title: Trends Immunol doi: 10.1016/S1471-4906(02)02255-X contributor: fullname: G Pawelec – volume: 64 start-page: 6337 year: 2004 ident: BFonc2008268_CR80 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-0757 contributor: fullname: P Serafini – volume: 195 start-page: 1303 year: 2002 ident: BFonc2008268_CR3 publication-title: J Exp Med doi: 10.1084/jem.20011624 contributor: fullname: G Andreola – volume: 13 start-page: 99 year: 2004 ident: BFonc2008268_CR35 publication-title: Int J Mol Med contributor: fullname: YJ Jung – volume: 65 start-page: 2457 year: 2005 ident: BFonc2008268_CR66 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-3232 contributor: fullname: LA Ormandy – volume: 87 start-page: 307 year: 1996 ident: BFonc2008268_CR32 publication-title: Cell doi: 10.1016/S0092-8674(00)81348-3 contributor: fullname: T Holtschke – volume: 13 start-page: 4016 year: 2007 ident: BFonc2008268_CR77 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-0016 contributor: fullname: RE Sadun – volume: 3 start-page: 666 year: 2003 ident: BFonc2008268_CR14 publication-title: Nat Rev Cancer doi: 10.1038/nrc1167 contributor: fullname: ME Dudley – volume: 5 start-page: 677 year: 1999 ident: BFonc2008268_CR48 publication-title: Nat Med doi: 10.1038/9525 contributor: fullname: PP Lee – volume: 16 start-page: 3 year: 2006 ident: BFonc2008268_CR100 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2005.07.008 contributor: fullname: TL Whiteside – volume: 11 start-page: 1314 year: 2005 ident: BFonc2008268_CR40 publication-title: Nat Med doi: 10.1038/nm1325 contributor: fullname: M Kortylewski – volume: 13 start-page: 721s year: 2007 ident: BFonc2008268_CR63 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-06-2197 contributor: fullname: AC Ochoa – volume: 192 start-page: 1027 year: 2000 ident: BFonc2008268_CR22 publication-title: J Exp Med doi: 10.1084/jem.192.7.1027 contributor: fullname: GJ Freeman – volume: 166 start-page: 678 year: 2001 ident: BFonc2008268_CR2 publication-title: J Immunol doi: 10.4049/jimmunol.166.1.678 contributor: fullname: B Almand – volume: 10 start-page: 789 year: 2004 ident: BFonc2008268_CR97 publication-title: Nat Med doi: 10.1038/nm1087 contributor: fullname: B Vogelstein – volume: 96 start-page: 2233 year: 1999 ident: BFonc2008268_CR64 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.5.2233 contributor: fullname: AF Ochsenbein – volume: 21 start-page: 685 year: 2003 ident: BFonc2008268_CR86 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.21.120601.141040 contributor: fullname: RM Steinman – volume: 65 start-page: 1089 year: 2005 ident: BFonc2008268_CR30 publication-title: Cancer Res doi: 10.1158/0008-5472.1089.65.3 contributor: fullname: F Hirano – volume: 56 start-page: 227 year: 2007 ident: BFonc2008268_CR9 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-006-0183-1 contributor: fullname: CC Chang – volume: 13 start-page: 4840 year: 2007 ident: BFonc2008268_CR23 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-0409 contributor: fullname: I Fricke – volume: 9 start-page: 1 year: 2007 ident: BFonc2008268_CR87 publication-title: Exp Rev Mol Med doi: 10.1017/S1462399407000233 contributor: fullname: TJ Stewart – volume: 7 start-page: 41 year: 2007 ident: BFonc2008268_CR106 publication-title: Nat Rev Immunol doi: 10.1038/nri1995 contributor: fullname: H Yu – volume: 198 start-page: 1741 year: 2003 ident: BFonc2008268_CR92 publication-title: J Exp Med doi: 10.1084/jem.20022227 contributor: fullname: M Terabe – volume: 22 start-page: 531 year: 2004 ident: BFonc2008268_CR78 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.21.120601.141122 contributor: fullname: S Sakaguchi – volume: 437 start-page: 141 year: 2005 ident: BFonc2008268_CR101 publication-title: Nature doi: 10.1038/nature03954 contributor: fullname: G Willimsky – volume: 31 start-page: 1260 year: 1999 ident: BFonc2008268_CR72 publication-title: Transplant Proc doi: 10.1016/S0041-1345(98)01987-3 contributor: fullname: I Penn – volume: 202 start-page: 931 year: 2005 ident: BFonc2008268_CR76 publication-title: J Exp Med doi: 10.1084/jem.20050715 contributor: fullname: PC Rodriguez – volume: 6 start-page: 409 year: 2004 ident: BFonc2008268_CR105 publication-title: Cancer Cell doi: 10.1016/j.ccr.2004.08.031 contributor: fullname: L Yang – volume: 110 start-page: 3192 year: 2007 ident: BFonc2008268_CR51 publication-title: Blood doi: 10.1182/blood-2007-06-094615 contributor: fullname: MT Litzinger – volume: 65 start-page: 3044 year: 2005 ident: BFonc2008268_CR108 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-4505 contributor: fullname: AH Zea – volume: 100 start-page: 2281 year: 2004 ident: BFonc2008268_CR37 publication-title: Cancer doi: 10.1002/cncr.20270 contributor: fullname: R Kim – volume: 107 start-page: 628 year: 2006 ident: BFonc2008268_CR109 publication-title: Blood doi: 10.1182/blood-2005-07-2737 contributor: fullname: G Zhou – volume: 201 start-page: 1591 year: 2005 ident: BFonc2008268_CR17 publication-title: J Exp Med doi: 10.1084/jem.20042167 contributor: fullname: AM Ercolini – volume: 67 start-page: 5064 year: 2007 ident: BFonc2008268_CR50 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-0912 contributor: fullname: EY Lin – volume: 66 start-page: 9299 year: 2006 ident: BFonc2008268_CR60 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-1690 contributor: fullname: N Mirza – volume: 209 start-page: 19 year: 2001 ident: BFonc2008268_CR29 publication-title: Cell Immunol doi: 10.1006/cimm.2001.1785 contributor: fullname: H Harizi – volume: 251 start-page: 1228 year: 1991 ident: BFonc2008268_CR67 publication-title: Science doi: 10.1126/science.1900952 contributor: fullname: GR Otten – volume: 4 start-page: 71 year: 2004 ident: BFonc2008268_CR74 publication-title: Nat Rev Cancer doi: 10.1038/nrc1256 contributor: fullname: JW Pollard – volume: 601 start-page: 213 year: 2007 ident: BFonc2008268_CR61 publication-title: Adv Exp Med Biol doi: 10.1007/978-0-387-72005-0_22 contributor: fullname: S Nagaraj – volume: 56 start-page: 739 year: 2007 ident: BFonc2008268_CR4 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-006-0272-1 contributor: fullname: C Blank – volume: 9 start-page: 4404 year: 2003 ident: BFonc2008268_CR33 publication-title: Clin Cancer Res contributor: fullname: F Ichihara – volume: 30 start-page: 251 year: 2007 ident: BFonc2008268_CR21 publication-title: J Immunother (1997) doi: 10.1097/CJI.0b013e31802e085a contributor: fullname: DB Flies – volume: 271 start-page: 1734 year: 1996 ident: BFonc2008268_CR47 publication-title: Science doi: 10.1126/science.271.5256.1734 contributor: fullname: DR Leach – volume: 18 start-page: 423 year: 2000 ident: BFonc2008268_CR81 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.18.1.423 contributor: fullname: EM Shevach – volume: 10 start-page: 942 year: 2004 ident: BFonc2008268_CR12 publication-title: Nat Med doi: 10.1038/nm1093 contributor: fullname: TJ Curiel – volume: 65 start-page: 4376 year: 2005 ident: BFonc2008268_CR55 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-4269 contributor: fullname: K Liu – volume: 298 start-page: 850 year: 2002 ident: BFonc2008268_CR15 publication-title: Science doi: 10.1126/science.1076514 contributor: fullname: ME Dudley – volume: 19 start-page: 203 year: 2007 ident: BFonc2008268_CR8 publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2007.02.001 contributor: fullname: JD Bui – volume: 170 start-page: 5973 year: 2003 ident: BFonc2008268_CR52 publication-title: J Immunol doi: 10.4049/jimmunol.170.12.5973 contributor: fullname: K Liu |
| SSID | ssj0007902 |
| Score | 2.4016848 |
| SecondaryResourceType | review_article |
| Snippet | It is now well established that the immune system can control neoplastic development and growth in a process termed immunosurveillance. A link between host... |
| SourceID | proquest gale crossref pubmed springer nature |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 5894 |
| SubjectTerms | Animal models Animals Apoptosis Cancer cells Carcinogenesis Cell Adhesion - immunology Cell Adhesion - physiology Cell Biology Cell Communication - immunology Cell Communication - physiology Cell-mediated immunity Cellular biology Cellular immunity Control Genetic aspects Genetics Health aspects Human Genetics Humans Immune response Immune system Immune Tolerance - immunology Immune Tolerance - physiology Immunology Immunosuppression Immunosurveillance Immunotherapy Internal Medicine Medicine Medicine & Public Health Microenvironments Models, Biological Neoplasms - immunology Oncology review Tumor Escape - immunology Tumor Escape - physiology Tumors |
| Title | How tumours escape mass destruction |
| URI | http://dx.doi.org/10.1038/onc.2008.268 https://link.springer.com/article/10.1038/onc.2008.268 https://www.ncbi.nlm.nih.gov/pubmed/18836470 https://www.proquest.com/docview/227359374 https://www.proquest.com/docview/2641386572 https://search.proquest.com/docview/19748898 https://search.proquest.com/docview/21340442 https://search.proquest.com/docview/69627288 |
| Volume | 27 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4VUFsuqN0-CNBtpL5OFonj-HGq6Aq0qgSqqiLtLUps50ZCySLUf9-ZxNllVUqutjzJ-PXZM_k-gI8u71WMHXMiE0wIZZh2ImG20tyKpJa6J0k6v5DzS_F9kS_ChVsX0irHNbFfqF1r6Y78GDfulPQpFf96_ZuRahRFV4OExhbspLTR0Z_is3WKhxpyDhFFJAyBDA-J70mmj9vGDomUnEhW721JYWHe5NXcwJ3_xEz7rejsBewFDBmfDJ3-Ep74ZgJPB1XJPxN4PhtF3Cbw7DzEzl_Bh3l7Fy9v8ah_08W-o8Sn-Aqhc-z8ikT2NVyenf6azVmQSGA2z-SSlV45o0rtM5uqMlWVJR2LGkFVJSWugTjdeJWVPqmN9hrhVV1a45zJ8fGuNNkb2G7axu9DXOd1JqRVtiLO-cpUtuaS1wLPMya1uY_g0-il4npgwij6CHamC_TmoGeJ3ozgC7mwoAmyvCltGfL80QpRTRUnKRHGIDCSERxt1ETX2I3iaOiElTk0Q1Z6I4djvxRh0nUFRyiWI9wS2PADpasBFMH7VTHZpDSzxre3XZHi6Upro_9fgwjwEiEeaUOSnBHX2MbbYbysvaU1sfUnEXweB9D69R5y5cHj33EIu3xk55VHsI1jxb9DiLSsprClFmraz4Yp7Hw7vfjx8y-izAx_ |
| link.rule.ids | 314,780,784,12056,12223,21388,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,73745,74014,74302 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BEZQLguUVWmgkXierieP4cULVimqBbk-t1JuV2M6tSWm2Qvx7ZhJnlxWluTryJOOx_dkz-j6AD74cVIw986IQTAhlmPYiY67W3ImskXogSVqeysW5-H5RXsQLtz6WVU5r4rBQ-87RHfkhbtw56VMq_uXqJyPVKMquRgmN-_AAt31FUa3nmxIPNdYcIorIGAIZHgvfs0Ifdq0bCyk5kaz-tSXFhXmbV3MLd_6TMx22ouOn8CRiyPRoHPRncC-0M3g4qkr-nsHufBJxm8GjZcydP4f3i-5XurrBo_51n4aeCp_SS4TOqQ9rEtkXcH789Wy-YFEigbmykCtWBeWNqnQoXK6qXNWOdCwaBFW1lLgG4nTjdVGFrDE6aIRXTeWM96bEJ_jKFC9hp-3a8BrSpmwKIZ1yNXHO16Z2DZe8EXieMbkrQwIfJy_Zq5EJww4Z7EJb9OaoZ4neTOAzudDSBFldV66Kdf5ohaim7FFOhDEIjGQC-1tvomvcVnMyDsLaHJohK4ORvWlcbJx0veUIxUqEWwI7vqV1HUAJHKybySaVmbWhu-ltjqcrrY3-_xtEgJcJcUcfkuSMuMY-Xo3xsvGW1sTWnyXwaQqgzefd5so3d__HAewuzpYn9uTb6Y89eMwnpl65DzsYN-EtwqVV_W6YE38A2m4M-g |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BEaWXChYKaQuNxNfJ2sRxHPtUVQur5aMVByr1ZiW2cyMpzVao_74zibPLitK9OvLsTmbs5_XTewDvXN67GDvmRCaYEIVmyomE2UpxK5Jaql4k6fRMLs7F14v8IvCfukCrHNfEfqF2raX_yKe4cafkT1nwaR1oET8-zY8vfzNykKKb1mCn8RAekcsc6eir2ZruUQz8Q0QUCUNQwwMJPsnUtG3sQKrkJLj61_YUFulNjc0NDPrP_Wm_Lc2fwm7Ak_HJUADP4IFvJvB4cJi8mcCT2WjoNoHt03CP_hzeLto_8fIaj_1XXew7IkHFvxBGx86vBGVfwPn888_ZggW7BGbzTC5Z6Quni1L5zKZFmRaVJU-LGgFWJSWuh9h6vMpKn9RaeYVQqy6tdk7n-PGu1NkebDVt419BXOd1JqQtbEX685WubM0lrwWebXRqcx_B-zFL5nJQxTD9bXamDGZz8LbEbEbwkVJoqFmWV6UtA-cfo5DslDlJSTwGQZKM4HDjSUyN3RiOhpewCodhKEof5GB8LyY0YGc4wrIcoZfAie8YXRVTBEerYYpJlLPGt9edSfGkpZRW_3-CxPASIe6ZQ5K1EVc4x8uhXtbZUoqU-5MIPowFtP56d6Vy__7fcQTb2A7m-5ezbweww0fRXnkIW1g2_jUip2X1pm-JW5fVER8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=How+tumours+escape+mass+destruction&rft.jtitle=Oncogene&rft.au=Stewart%2C+T+J&rft.au=Abrams%2C+S+I&rft.date=2008-10-06&rft.eissn=1476-5594&rft.volume=27&rft.issue=45&rft.spage=5894&rft_id=info:doi/10.1038%2Fonc.2008.268&rft_id=info%3Apmid%2F18836470&rft.externalDocID=18836470 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon |